Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,48956,0.00741800627780016,0.0124059888465176,-0.0168977318613743,0.0317337444169746,0.54988714574962
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,45259,0.0290946898936365,0.0141316804226292,0.00139659626528335,0.0567927835219897,0.039523202280137
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1070.Time spent watching television (TV),50534,0.00813381652357015,0.0125790101514986,-0.0165210433733672,0.0327886764205075,0.517884785525534
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1080.Time spent using computer,45221,-0.0334963163634912,0.0133635254375973,-0.0596888262211819,-0.00730380650580049,0.0121992335975053
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X1090.Time spent driving,42596,0.00786228988894714,0.0145903955850008,-0.0207348854576545,0.0364594652355488,0.589984900489058
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1160.Sleep duration,52067,-0.00739367152709359,0.0114142880050549,-0.0297656760170013,0.0149783329628141,0.517148277404378
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34136,0.0642074018988938,0.0329814762377826,-0.000436291527160015,0.128851095324948,0.0515909953737167
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34136,0.051388264983857,0.0296254075115947,-0.00667753373886852,0.109454063706583,0.0828433000701203
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34136,-0.0587226653662229,0.0353986509855625,-0.128104021297925,0.0106586905654795,0.0971692204235286
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34136,0.0127561528441627,0.0362708084432442,-0.0583346317045959,0.0838469373929213,0.725076919321046
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34136,-0.0272455415214827,0.0366281462187866,-0.0990367081103044,0.044545625067339,0.456990313125366
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34136,-0.0696299893924333,0.0699153311067117,-0.206664038361588,0.0674040595767215,0.319314506522768
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34136,0.0537980111055463,0.0698973023695203,-0.0832007015387134,0.190796723749806,0.441513132602774
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34136,-0.0121991731661721,0.0539767402687874,-0.117993584092995,0.0935952377606511,0.821199995936253
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34136,-0.0387539817321758,0.0386430290268186,-0.11449431862474,0.0369863551603887,0.31594805707407
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34136,0.0116016501637984,0.0266308694468608,-0.0405948539520489,0.0637981542796456,0.663102798566873
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34136,0.0216640172685422,0.0371115061721982,-0.0510745348289663,0.0944025693660507,0.559398935257456
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34136,0.0074224064235193,0.0226994834787715,-0.0370685811948728,0.0519133940419114,0.74368577056127
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34136,0.0414142125036848,0.0282804137834019,-0.0140153985117828,0.0968438235191525,0.143113532200179
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34136,0.0646902140355326,0.0405538962405377,-0.0147954225959212,0.144175850666986,0.110707654717592
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34136,0.0357391049705583,0.0385858610087059,-0.0398891826065053,0.111367392547622,0.354353277342131
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34136,0.0415412212835739,0.0541280658406305,-0.0645497877640618,0.14763223033121,0.44282572504956
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34136,0.00136524706385398,0.0501413410335273,-0.0969117813618596,0.0996422754895675,0.978278466042668
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34136,0.0260870384898811,0.0302703103942928,-0.0332427698829329,0.085416846862695,0.388817378422257
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34136,-0.000670305202890599,0.0282729371683508,-0.0560852620528581,0.054744651647077,0.981085719545769
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34136,0.0244068789404467,0.0377349228081238,-0.049553569763476,0.0983673276443695,0.517777907649786
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,34143,-0.00886622820214997,0.0196046327681965,-0.0472913084278152,0.0295588520235153,0.65109780259268
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34139,-0.00165650327377047,0.0195270654813895,-0.0399295516172939,0.036616545069753,0.932397388066436
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34139,0.0112026404812744,0.0209786875075752,-0.0299155870335731,0.0523208679961218,0.59335308593789
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120098.Mobility problems today,34146,0.0228150781092033,0.0232647406799681,-0.0227838136235343,0.0684139698419408,0.326779032027287
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120099.Self-care problems today,34146,0.0042834625399765,0.0367167883820177,-0.0676814426887782,0.0762483677687311,0.90713013656481
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120100.Problems doing usual activities,34146,0.0312018322709488,0.0220543373516977,-0.0120246689383786,0.0744283334802763,0.15716784033715
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120101.Pain or discomfort today,34146,0.0212317417631022,0.0197229542190615,-0.0174252485062583,0.0598887320324627,0.281730916657387
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120102.Anxiety or depression today,34146,0.0143760962242716,0.0231165269627685,-0.0309322966227545,0.0596844890712978,0.534024300106242
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,34108,0.000908087795174807,0.00980737464620431,-0.0183143665113856,0.0201305421017352,0.926229348048432
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34122,-0.00503355755852691,0.0238299430116158,-0.051740245861294,0.0416731307442401,0.832713606705856
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34098,0.0271473367398735,0.0239631728674486,-0.0198204820803257,0.0741151555600726,0.257293909659211
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34128,0.0139203439504584,0.0194056516633087,-0.0241147333096267,0.0519554212105436,0.473185027702601
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34123,0.00705078255466215,0.0199058708392874,-0.0319647242903412,0.0460662893996655,0.723192093155368
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34132,-0.0103314548963668,0.0241311427383531,-0.0576284946635389,0.0369655848708053,0.668560308923234
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34101,0.00965272938417126,0.0250870874661261,-0.0395179620494359,0.0588234208177785,0.700417173753731
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34127,-0.0114361705344164,0.0259399031058244,-0.0622783806218321,0.0394060395529994,0.659315697429828
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34118,0.00186252690737006,0.0378696357130128,-0.0723619590901349,0.076087012904875,0.960774799054567
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34079,-0.0224026568900151,0.0508567063816767,-0.122081801398101,0.0772764876180711,0.659580950470508
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31750,0.00759076625205025,0.0260545444324898,-0.0434761408356297,0.0586576733397302,0.770798544679098
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49701,0.0254042107141547,0.0277669899065908,-0.0290190895027633,0.0798275109310726,0.360249243787836
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47839,0.0262739930289127,0.0180070952158853,-0.00901991359422253,0.061567899652048,0.144553456287683
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51527,-0.0186717055485448,0.0119009969155934,-0.0419976595031079,0.00465424840601835,0.116678395354615
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,51017,-0.0432287985699915,0.012869648013951,-0.0684533086773356,-0.0180042884626474,0.000783427144382511
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51568,-0.0182368275994703,0.0123567647869883,-0.0424560865819674,0.00598243138302688,0.139993684281925
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,49808,-0.0109114435524666,0.0124457350931314,-0.0353050843350041,0.013482197230071,0.380646231618204
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52358,0.00485507718825399,0.020556197886818,-0.0354350706699093,0.0451452250464172,0.813290414632729
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52358,0.0404985399865677,0.0118230863614491,0.0173252907181274,0.063671789255008,0.000614828075301634
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52358,-0.00293776220424265,0.0119658728582102,-0.0263908730063347,0.0205153485978494,0.806062028592305
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52358,0.0440138416221328,0.0116063225399713,0.0212654494437891,0.0667622338004765,0.000149615168878937
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1438.Bread intake,51411,-0.00227788889648191,0.00644022671658937,-0.0149007332609971,0.0103449554680333,0.723568733782285
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1458.Cereal intake,50947,-0.000371178389875363,0.0118102301153506,-0.0235192294159626,0.0227768726362118,0.974928010727277
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1488.Tea intake,51431,-0.0103220908785416,0.00599946803327595,-0.0220810482237625,0.00143686646667922,0.0853528747990844
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1498.Coffee intake,50136,0.0109842441239777,0.0119524226934766,-0.0124425043552365,0.0344109926031919,0.358105617711506
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X1528.Water intake,50607,0.0112089384195869,0.0121487444877233,-0.0126026007763509,0.0350204776155246,0.356202461599724
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,41519,-0.0192908643046804,0.0144470330057752,-0.0476070489959997,0.00902532038663893,0.181801850575674
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41519,0.0149741482671884,0.0144982212335075,-0.0134423653504863,0.0433906618848631,0.301699697820631
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,41544,-0.00760447030321799,0.0182465704661,-0.0433677484167739,0.0281588078103379,0.67685801032937
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,41474,0.0210804651301902,0.0162692075046421,-0.0108071815789084,0.0529681118392888,0.195086836391376
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,41552,0.0618306933684146,0.0249944868074134,0.0128414992258843,0.110819887510945,0.0133790882392451
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45720,-0.0303030017011156,0.0141694403469478,-0.0580751047811333,-0.00253089862109796,0.0324780822484635
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1807.Father's age at death,44817,0.00449011496293734,0.00692293347308631,-0.00907883464431182,0.0180590645701865,0.516613578533534
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1845.Mother's age,35324,0.0239791134060138,0.0158507817358819,-0.0070884187963148,0.0550466456083423,0.130358721264761
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1873.Number of full brothers,51842,-0.00796969501649678,0.0114587880051211,-0.0304289195065342,0.0144895294735407,0.486742009809222
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X1883.Number of full sisters,51849,0.024156415677077,0.0114738380397484,0.00166769311917024,0.0466451382349838,0.0352701531295026
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20015.Sitting height,52164,-0.0223581274542086,0.00795102418360717,-0.0379421348540786,-0.00677412005433851,0.00492720346394822
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20016.Fluid intelligence score,33402,0.0045690741461483,0.0196740584119788,-0.0339920803413302,0.0431302286336267,0.816358080339204
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20018.Prospective memory result,33743,-0.0182603068279051,0.026212333631006,-0.0696364807446768,0.0331158670888665,0.486051594631056
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33273,-0.0112355879771127,0.0105935360766739,-0.0319989186873936,0.00952774273316814,0.288897172549071
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33245,-0.00858667739675343,0.0105458821137384,-0.0292566063396807,0.0120832515461738,0.415540476286645
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,52043,0.00312756600778021,0.00649483390810864,-0.00960230845211272,0.0158574404676731,0.630131797597727
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,49104,0.00496598455759788,0.0133272121324354,-0.0211553512219754,0.0310873203371712,0.709434557248085
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48673,-0.0165422970762998,0.028889900975372,-0.073166502988029,0.0400819088354293,0.566922286344692
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48642,0.0652661429049437,0.0393257566835695,-0.0118123401948526,0.14234462600474,0.0970021924977963
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48657,0.024794994128088,0.031704074820426,-0.037344992519947,0.086934980776123,0.43417759562199
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48660,0.00132025933250399,0.0237829128081492,-0.0452942497714685,0.0479347684364764,0.955730281993575
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48824,-0.0268650018462025,0.0172954243589395,-0.060764033589724,0.00703402989731903,0.120364199811713
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48760,-0.0175323300455752,0.0217310182732169,-0.0601251258610804,0.02506046576993,0.419796387474725
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48668,-0.0864897989056546,0.0277938835847133,-0.140965810731693,-0.0320137870796166,0.00186148709272872
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48819,0.00966187405245286,0.0195796154634595,-0.0287141722559278,0.0480379203608335,0.621687822307705
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48874,0.00272934172814345,0.0148047112139668,-0.0262878922512315,0.0317465757075184,0.853735483266094
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48745,-0.00912924510270309,0.0207017700377819,-0.0497047143767557,0.0314462241713495,0.659225156374754
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50497,0.00616951620171521,0.0147834152455677,-0.0228059776795974,0.0351450100830279,0.676442787472257
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50367,0.0474989884369835,0.0215714527386026,0.00521894106932249,0.0897790358046446,0.0276785082348578
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50298,-0.027395011983968,0.0461123818719031,-0.117775280452898,0.062985256484962,0.552455566151729
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50334,0.0234539809098808,0.023273010060393,-0.0221611188084895,0.0690690806282511,0.313571432952867
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50430,0.0139813132497997,0.0169926149406561,-0.0193242120338863,0.0472868385334857,0.410636328845105
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50322,-0.0524033589866006,0.0314166904086139,-0.113980072187484,0.00917335421428266,0.0953258111353297
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50318,0.0143682459651195,0.0277996688904308,-0.0401191050601247,0.0688555969903638,0.605265616398321
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50346,-0.00606402115709226,0.0221505772017953,-0.049479152472611,0.0373511101584264,0.784268502658039
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50363,0.0443959938019255,0.024727176956313,-0.00406927303244788,0.0928612606362989,0.0725963590996968
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50523,0.0126931794921252,0.0128387131684251,-0.012470698317988,0.0378570573022384,0.322836509404797
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50378,0.0118722442081102,0.0202125542679641,-0.0277443621570993,0.0514888505733198,0.55696047875557
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46842,-0.0231282426338258,0.0209021258372824,-0.0640964092748993,0.0178399240072478,0.268521216094775
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46698,0.0415530558819148,0.0814395971137464,-0.118068554461028,0.201174666224858,0.609894278965323
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46695,0.00753555088460701,0.0852913886612979,-0.159635570891537,0.174706672660751,0.92959876710396
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46760,-0.00859729023384786,0.0231438791841161,-0.0539592934347153,0.0367647129670196,0.710289948678399
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46710,0.0223032847556071,0.0490798170946265,-0.0738931567498608,0.118499726261075,0.649524624123816
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46724,-0.0341882549004965,0.0356105960228404,-0.103985023105264,0.0356085133042707,0.337036202548754
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46705,0.0623192758140205,0.0432541020740601,-0.0224587642511372,0.147097315879178,0.149663328436783
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46702,0.0219692280152353,0.0421011833852483,-0.0605490914198514,0.104487547450322,0.601801047604388
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46720,-0.0111559791313757,0.0308419452199396,-0.0716061917624574,0.0492942334997059,0.717568814188188
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46723,-0.00267464927714645,0.0371717910478853,-0.0755313597310017,0.0701820611767088,0.942639371003169
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46916,-0.00980907838505256,0.0154180622161095,-0.0400284803286271,0.020410323558522,0.524648023658634
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46798,0.0377072610284692,0.0221403251102528,-0.00568777618762629,0.0811022982445647,0.088562642105149
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20127.Neuroticism score,46378,0.020595968669758,0.0120319320725061,-0.00298661819235392,0.04417855553187,0.0869521648276826
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33402,0.0347956982351093,0.0201289715391662,-0.00465708598165644,0.0742484824518751,0.083908495013045
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,31895,0.019986988206034,0.0130941486670853,-0.00567754318145319,0.0456515195935212,0.126951247713734
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31895,0.0198766399335408,0.0129204859558636,-0.00544751253995188,0.0452007924070334,0.123997801936536
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20191.Fluid intelligence score,31537,0.0127059944440125,0.0215436031965706,-0.0295194678212659,0.054931456709291,0.555356738399812
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31537,0.0335693866479318,0.0221028313531237,-0.00975216280419074,0.0768909361000543,0.128862025139263
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,30781,0.0242575178595582,0.0232565457220253,-0.0213253117556113,0.0698403474747277,0.296969449023529
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X20255.Spirometry QC measure,45912,0.0394442993953299,0.0158733966413954,0.00833244197819499,0.0705561568124648,0.0129652056534677
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20261.avMSE,30516,-0.0308694826517901,0.0120234229385671,-0.0544353916113816,-0.00730357369219852,0.0102688469910993
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X20262.Myopia diagnosis,30516,0.0292281347535928,0.0302767789651061,-0.0301143520180152,0.0885706215252008,0.334400660136373
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,40378,0.0830880875472577,0.00823941110700009,0.0669388417775375,0.0992373333169779,7.64977209526832e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40415,0.0930788086652416,0.00787365040065922,0.0776464538799495,0.108511163450534,4.11154353000255e-32
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33223,0.0141998372054359,0.0378930777665014,-0.0600705952169068,0.0884702696277787,0.707867115936649
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33220,0.0397356130952368,0.0706980090675565,-0.0988324846771739,0.178303710867648,0.574098275712152
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33219,-0.151825281925625,0.0876381913062691,-0.323596136885913,0.0199455730346623,0.0832357520619632
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33219,0.0123352518159247,0.0354954154255223,-0.0572357624180991,0.0819062660499484,0.728211470772269
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33219,0.0504841803699735,0.0699604956004603,-0.0866383910069287,0.187606751746876,0.470553646430711
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33226,-0.0208924813987176,0.0866364667803986,-0.190699956288299,0.148914993490864,0.809443624888258
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33226,-0.0372419319999735,0.0571926136310659,-0.149339454716863,0.0748555907169157,0.514955863451719
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33226,-0.0647467137341153,0.062814896528446,-0.187863910929869,0.0583704834616388,0.302684547729894
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33226,0.00798006447163432,0.103078098503046,-0.194053008594336,0.210013137537604,0.938293063053791
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33226,0.109402461906569,0.125380931851192,-0.136344164521767,0.355149088334905,0.382926497910857
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33226,-0.104680736491615,0.0650261708179264,-0.23213203129475,0.0227705583115212,0.10747210359252
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33226,0.0791590422179735,0.126444789097462,-0.168672744413052,0.326990828848998,0.531307342684886
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33226,0.0725657615675156,0.0862687556308749,-0.0965209994689992,0.24165252260403,0.400281650800529
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33225,0.00679233969427621,0.101453073096486,-0.192055683574837,0.20564036296339,0.946622590718639
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33225,-0.0300734708811126,0.048013776808779,-0.124180473426319,0.0640335316640943,0.531101123132496
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33225,-0.0304451681510154,0.0774916274609448,-0.182328757974467,0.121438421672437,0.694415204810766
PLA2G4A,Cytosolic phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33227,0.0591738302702374,0.115053081229225,-0.166330208939043,0.284677869479518,0.607042876409448
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,35087,-0.00160297271886821,0.0175366272829661,-0.0359747621934818,0.0327688167557453,0.9271708218535
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,35087,-0.0217575740421601,0.017416146097685,-0.0558932203936227,0.0123780723093024,0.211591645888797
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,35087,0.0450345600371957,0.017484310911005,0.010765310651626,0.0793038094227654,0.0100167620969212
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20603.Liking for apples,35087,3.30783763258697e-05,0.017865701917838,-0.0349836973826367,0.0350498541352884,0.998522751030534
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,35087,-0.0172090588479112,0.0178699979953225,-0.0522342549187434,0.017816137222921,0.335562394800556
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,35087,-0.0152869426851227,0.0175015889740224,-0.0495900570742065,0.0190161717039612,0.382431989140254
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20606.Liking for avocados,35087,0.0190275460207517,0.0178895382329674,-0.0160359489158643,0.0540910409573678,0.287528205416514
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20607.Liking for bacon,35087,0.00272433047101919,0.0175880697797828,-0.031748286297355,0.0371969472393934,0.87690585396693
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,35087,-0.00748874785464098,0.0179450428460219,-0.0426610318328439,0.027683536123562,0.676455947973226
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20609.Liking for bananas,35087,0.00596374011890994,0.0182630962746102,-0.0298319285793261,0.0417594088171459,0.744017761211457
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35087,-0.0322662649704532,0.0175930017111401,-0.0667485483242878,0.00221601838338138,0.0666760382263561
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,35087,-0.0111835161204458,0.0175316070238566,-0.0455454658872048,0.0231784336463132,0.523548661688908
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,35087,-0.0043437302999575,0.0179513566152812,-0.0395283892659087,0.0308409286659937,0.80880632869149
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,35087,-0.00650130271955623,0.0176816695375185,-0.0411573750130924,0.02815476957398,0.71311468810569
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,35087,-0.00402789694660605,0.0175285194708292,-0.0383837951094313,0.0303280012162192,0.818258560410914
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,35087,0.0149118074080842,0.0176129453853956,-0.0196095655472912,0.0494331803634596,0.397215405459419
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,35087,-0.0161301773549554,0.0175170799914684,-0.0504636541382335,0.0182032994283227,0.357162342015839
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,35087,-0.00257981179684678,0.0181801018707278,-0.0382128114634732,0.0330531878697797,0.887159280023705
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20618.Liking for black olives,35087,-0.0299806206667182,0.0176446077972987,-0.0645640519494236,0.00460281061598727,0.0893224875117226
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,35087,0.0140746742138339,0.0177367381867872,-0.020689332632269,0.0488386810599368,0.427485491418132
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,35087,0.0190912211473765,0.0175553133576365,-0.0153171930335911,0.0534996353283442,0.276845147136645
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,35087,-0.00631303404298906,0.0176002072043953,-0.0408094401636039,0.0281833720776257,0.719833467888782
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,35087,-0.00602948538411322,0.0175689210153611,-0.040464570574221,0.0284055998059945,0.731462000407847
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,35087,-0.0188925418802824,0.0184109374943417,-0.0549779793691922,0.0171928956086273,0.304840189860699
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,35087,0.00668785772373682,0.0176161615528781,-0.0278398189199043,0.041215534367378,0.704217800280715
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,35087,0.0109003926405241,0.0177484993705798,-0.0238866661258122,0.0456874514068605,0.539123709202716
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),35087,-0.0134069054533327,0.0175987627716127,-0.0479004804856936,0.0210866695790283,0.446190590513842
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,35087,-0.0152247502210431,0.0176178676012549,-0.0497557707195027,0.0193062702774164,0.387516585739373
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,35087,0.0327873263866914,0.0178421166840553,-0.00218322231405697,0.0677578750874397,0.0661438773549702
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,35087,-0.0309319055206529,0.0175396962127865,-0.0653097100977145,0.00344589905640866,0.0778386751718493
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,35087,-0.00337975722467175,0.0178773388347486,-0.038419341340779,0.0316598268914355,0.850055208932776
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20631.Liking for cake,35087,0.00754597865369814,0.0176544618316068,-0.0270567665362512,0.0421487238436475,0.669077624939315
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,35087,0.00910666108959543,0.0174524963532236,-0.0251002317627228,0.0433135539419137,0.601822520593555
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20633.Liking for capers,35087,-0.040865789253134,0.017400331676132,-0.0749704393383528,-0.00676113916791519,0.0188641925256021
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,35087,-0.00152516574904974,0.0180406125221582,-0.0368847662924798,0.0338344347943803,0.932628148890911
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,35087,0.0138727171236137,0.0174848838411438,-0.0203976552050281,0.0481430894522556,0.427555521832359
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,35087,0.0381603475796516,0.0175429257003597,0.00377621320694652,0.0725444819523567,0.0296329385186194
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20637.Liking for cherries,35087,0.0113089063422406,0.0190525720714377,-0.0260341349177772,0.0486519476022584,0.552816910172264
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20638.Liking for chicken,35087,-0.0202448788635722,0.018627592021323,-0.0567549592253653,0.0162652014982209,0.27714008686461
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,35087,-0.0416154622218139,0.0175420139549256,-0.0759978095734681,-0.00723311487015981,0.0176939538207269
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,35087,-0.0166643956601879,0.0176184757309889,-0.0511966080929262,0.0178678167725503,0.344247752786188
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,35087,-0.0372312853455255,0.0290393013868789,-0.0941483160638082,0.0196857453727572,0.199835575524506
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20642.Liking for cod,35087,-0.00160144472845752,0.0181140665334129,-0.0371050151339468,0.0339021256770317,0.929553352467327
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,35087,-0.00323218350744156,0.0200543206766406,-0.0425386520336571,0.036074285018774,0.871961447800858
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,35087,-0.00953865764715191,0.0180016743763193,-0.0448219394247377,0.0257446241304338,0.596208884249339
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20645.Liking for coriander,35087,-0.029391095630123,0.0175989930114338,-0.0638851219325332,0.00510293067228722,0.0949400785048492
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,35087,0.017721737489942,0.0174833449823665,-0.0165456186754963,0.0519890936553803,0.310779835926393
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20647.Liking for cream,35087,0.00790331161677761,0.0174529717224744,-0.0263045129592723,0.0421111361928275,0.65067700360841
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20648.Liking for croissant,35087,0.0150257075147429,0.0175273571825384,-0.0193279125630324,0.0493793275925182,0.391314071397002
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,35087,-0.0149446364687791,0.0177241252786489,-0.0496839220149311,0.0197946490773728,0.399146492657736
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20650.Liking for curry,35087,-0.0417423239962144,0.0177397036596034,-0.0765121431690371,-0.00697250482339179,0.0186384967408428
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,35087,0.0483507518262144,0.0178186024273467,0.0134262910686148,0.083275212583814,0.00666841828976627
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,35087,0.00221933413776398,0.0177098191644408,-0.03249191142454,0.036930579700068,0.900275289886897
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35087,0.00262909874152778,0.0183413141971046,-0.0333198770847973,0.0385780745678529,0.886022026556462
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,35087,-0.00867960995007346,0.0176542446493968,-0.0432819294628912,0.0259227095627443,0.622980927869859
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20655.Liking for eggs,35087,-0.00678774507512085,0.0182916113632205,-0.0426393033470331,0.0290638131967914,0.710581520131333
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,35087,0.0162255861013554,0.0175045271651315,-0.0180832871423023,0.0505344593450131,0.353980528926233
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,35087,0.00767988674375334,0.0176322005718456,-0.026879226377064,0.0422389998645707,0.663164619932457
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35087,-0.0219757305360088,0.0178934357240051,-0.0570468645550588,0.0130954034830412,0.219419807715553
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,35087,0.0136742565747935,0.0175600087605211,-0.0207433605958278,0.0480918737454148,0.436164476770223
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,35087,0.0012730662760554,0.0193340913844616,-0.0366217528374894,0.0391678853896002,0.947501931325832
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,35087,0.00267292897513977,0.0174236971554262,-0.0314775174494955,0.036823375399775,0.878079701043888
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,35087,0.0169016639903379,0.0176193580487499,-0.0176322777852119,0.0514356057658878,0.337446216676124
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20663.Liking for fruit,35087,0.0203390272186238,0.0203268637049941,-0.0195016256431646,0.0601796800804123,0.317043790545225
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20664.Liking for garlic,35087,-0.0247264807591659,0.0178250299762283,-0.0596635395125733,0.0102105779942416,0.165416734279325
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,35087,-0.0285923132312649,0.0174837931395476,-0.0628605477847783,0.00567592132224841,0.102003014146337
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,35087,-0.0115312097881722,0.0175910017538635,-0.0460095732257446,0.0229471536494002,0.512148803480536
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,35087,-0.0137373477290247,0.017527444062096,-0.0480911380907329,0.0206164426326836,0.433197139996375
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,35087,-0.00468720967510787,0.0176552856060058,-0.0392915694628793,0.0299171501126636,0.790641180641804
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,35087,-0.00197529125655617,0.0174790898942008,-0.0362343074491897,0.0322837249360774,0.910025700496291
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,35087,-0.00546012639128118,0.0174513541498486,-0.0396647805249844,0.028744527742422,0.754380293411849
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,35087,-0.00927657534977711,0.0174390439545544,-0.0434571015007038,0.0249039508011496,0.594776674904737
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20672.Liking for green olives,35087,-0.00862730150907877,0.0177108057703977,-0.0433404808190582,0.0260858778009007,0.626182789814987
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20673.Liking for haddock,35087,-0.00813004878507602,0.0179679649530405,-0.0433472600930353,0.0270871625228833,0.650936311198152
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20674.Liking for ham,35087,0.00161584150300618,0.0175795264631585,-0.0328400303647845,0.0360717133707969,0.926766432754587
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,35087,0.0271679621199119,0.0180484980626717,-0.0082070940829245,0.0625430183227484,0.132282981746936
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20676.Liking for herring,35087,0.0136182051388811,0.0174438824723731,-0.0205718045069702,0.0478082147847324,0.435004239795532
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20677.Liking for honey,35087,0.0209362854281678,0.0174606785346531,-0.0132866444997523,0.0551592153560878,0.230533931940085
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35087,-0.0233254398573222,0.0175246158867184,-0.0576736869952903,0.0110228072806459,0.183214261394008
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,35087,0.0208422332894731,0.0175825836138229,-0.0136196305936197,0.0553040971725659,0.235889465898446
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20680.Liking for jam,35087,0.0101797264012035,0.0174613512094628,-0.0240445219693437,0.0444039747717506,0.55991497665014
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,35087,0.00900019159390056,0.0176414687135414,-0.0255770870846407,0.0435774702724418,0.609941237015754
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20682.Liking for lager,35087,-0.0246864905723478,0.0176799800344013,-0.0593392514397743,0.00996627029507879,0.162654456556767
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20683.Liking for lamb,35087,-0.0129063953422595,0.0177191111841086,-0.0476358532631124,0.0218230625785934,0.466391902985477
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20684.Liking for lemons,35087,-0.0221763225830631,0.0176176215193571,-0.056706860761003,0.0123542155948767,0.20814539695602
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,35087,-0.0292397635788798,0.0177021239209829,-0.0639359264640063,0.00545639930624681,0.098611842475297
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20686.Liking for liver,35087,0.0343309302631271,0.0176627864732746,-0.000288131224491145,0.0689499917507454,0.0519595596884841
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,35087,-0.0117123737789841,0.0175020178574547,-0.0460163287795953,0.0225915812216271,0.503381591374943
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,35087,-0.0154785269582531,0.0174072731368921,-0.0495967823065616,0.0186397283900553,0.373916358996157
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,35087,0.00192733787576846,0.0175065447083717,-0.0323854897526402,0.0362401655041771,0.912338158484512
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20690.Liking for melon,35087,0.00661323728483295,0.0184333466645147,-0.0295161221776159,0.0427425967472818,0.719778120161565
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,35087,0.0321255364984652,0.0176600909176182,-0.00248824170006653,0.066739314696997,0.0689237441976212
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,35087,0.000339533937116585,0.0182639511401764,-0.0354578102976291,0.0361368781718623,0.98516821985533
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,35087,0.0283801275643455,0.0174536574173239,-0.00582904097360931,0.0625892961023004,0.103973451390431
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20695.Liking for oranges,35087,-0.0279371316970067,0.0179588372231584,-0.0631364526543972,0.00726218926038383,0.119828190430015
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20696.Liking for pasta,35087,0.00162341463517397,0.0177082380992604,-0.0330847320393764,0.0363315613097243,0.926957454673807
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20697.Liking for pears,35087,0.0134116061308185,0.0180137148901201,-0.0218952750538169,0.0487184873154539,0.456577231721345
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20698.Liking for pizza,35087,-0.0227730916217729,0.017559644406133,-0.0571899946577937,0.0116438114142478,0.194693975731323
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,35087,0.00851354222902487,0.0177343033744916,-0.0262456923849786,0.0432727768430283,0.631194108036479
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20700.Liking for plums,35087,0.0185283107183598,0.0180495355521068,-0.0168487789637695,0.0539054004004892,0.304667259262602
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20701.Liking for pollock,35087,0.00692198014066349,0.0174562264732441,-0.0272922237468949,0.0411361840282219,0.691719396332616
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,35087,0.00900580717370658,0.0174857349899446,-0.0252662334065848,0.0432778477539979,0.606537611249395
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20703.Liking for porridge,35087,0.023741126656686,0.0180643569487534,-0.0116650129628706,0.0591472662762426,0.188789607741717
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,35087,0.0113520317329303,0.0175751470327776,-0.0230952564513139,0.0457993199171745,0.51834906636234
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,35087,-0.00598860953322754,0.0178521797269108,-0.0409788817979726,0.0290016627315175,0.737288228520761
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20706.Liking for prawns,35087,-0.0122949982303813,0.0178705587271446,-0.0473212933355848,0.0227312968748221,0.491465902621965
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,35087,-0.00269892722445682,0.0178845471636251,-0.037752639665162,0.0323547852162484,0.880050890386665
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20708.Liking for red meat,35087,-0.0133864231832121,0.0175975705029174,-0.0478776613689301,0.0211048150025059,0.446854807154138
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20709.Liking for red wine,35087,-0.016585085136454,0.0175376588538251,-0.0509588964899512,0.0177887262170433,0.344331237514974
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35087,0.0320690983457139,0.018486049641451,-0.00416355895153013,0.0683017556429578,0.0828100307130832
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,35087,-0.000166847976670038,0.018683518780364,-0.0367865447861834,0.0364528488328433,0.992874975823216
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,35087,-0.0258723087638383,0.0175777491057092,-0.0603246970110282,0.00858007948335165,0.141083339431524
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,35087,0.00814024867770533,0.0182730052883161,-0.0276748416873942,0.0439553390428049,0.65598236953863
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20714.Liking for salami,35087,-0.026258367291086,0.0176011128289182,-0.0607565484357656,0.00823981385359366,0.135765967305505
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20715.Liking for salmon,35087,-0.0281178122985363,0.01879402012438,-0.064954091742321,0.00871846714524843,0.134656204347012
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,35087,0.0154686953984396,0.0174714093717587,-0.0187752669702075,0.0497126577670867,0.375976102072367
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,35087,0.0136917813716187,0.0174361130758863,-0.0204830002571185,0.0478665630003559,0.432322038832381
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20718.Liking for sardines,35087,0.00318765791153728,0.0174835101181254,-0.0310800219199885,0.037455337743063,0.855332193858616
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),35087,0.000174295416524211,0.0175140959826427,-0.0341533327094555,0.034501923542504,0.992059992444241
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,35087,0.0439386377928314,0.0176793219794757,0.00928716671305899,0.0785901088726039,0.0129590429426489
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35087,-0.0194371980858456,0.0174977030876777,-0.0537326961376939,0.0148582999660027,0.266661140294271
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,35087,-0.00329102699282155,0.0175070078815825,-0.0376047624407232,0.0310227084550801,0.850893247864368
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,35087,0.00556360918603725,0.0176029976732981,-0.028938266253627,0.0400654846257015,0.751962927194927
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,35087,0.0414113587160551,0.0174941358920927,0.00712285236755342,0.0756998650645567,0.0179431636771369
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,35087,-0.00153538923521968,0.0175492427753786,-0.0359319050749617,0.0328611266045223,0.930283411331507
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,35087,-0.0344383474654968,0.0176092287541749,-0.0689524358236796,7.5740892686034e-05,0.0505268145240638
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,35087,-0.0508998372606401,0.0176014569461628,-0.0853986928751192,-0.0164009816461609,0.00383822535776764
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20728.Liking for spinach,35087,0.00579907214865875,0.0178013523676176,-0.0290915784918717,0.0406897227891892,0.744607955624783
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20729.Liking for spirits,35087,-0.0029002209583105,0.0175024470289685,-0.0372050171350887,0.0314045752184677,0.86839325384757
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,35087,0.0089601813784923,0.0200343988243611,-0.0303072403172554,0.04822760307424,0.654711012729597
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35087,0.0184492118357629,0.0181589459905872,-0.017142322305788,0.0540407459773138,0.30965979030721
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,35087,0.0170768663230229,0.0175239351095121,-0.0172700464916208,0.0514237791376666,0.329836425200763
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,35087,0.0120460482185746,0.0179800994232212,-0.0231949466509389,0.0472870430880882,0.502894273648971
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,35087,0.013736610838143,0.023369045869838,-0.0320667190667395,0.0595399407430254,0.556670828981225
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,35087,-0.0205502544050425,0.0188009940491632,-0.0574002027414025,0.0162996939313174,0.274400646129105
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,35087,0.0102181702229376,0.0174628096930724,-0.0240089367754844,0.0444452772213596,0.558466711973961
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,35087,0.0047509151233318,0.0176509968121251,-0.0298450386284334,0.0393468688750971,0.787812970796091
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),35087,-0.0125082281877511,0.0174162530878046,-0.0466440842398481,0.0216276278643459,0.472654184883172
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,35087,0.0366864297066522,0.0204435998372906,-0.00338302597443741,0.0767558853877419,0.0727587716495291
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,35087,-0.0343400653602564,0.0174809872977055,-0.0686028004637591,-7.73302567537298e-05,0.0495070012847565
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20741.Liking for watching television,35087,-0.00119036039761267,0.017713416483271,-0.0359086567048238,0.0335279359095984,0.946422904082278
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20742.Liking for whisky,35087,-0.0179167458436768,0.0186807230249998,-0.0545309629726764,0.0186974712853227,0.337528455939272
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20743.Liking for white bread,35087,0.0029673695945526,0.0173376552229381,-0.0310144346424061,0.0369491738315113,0.864107724221817
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20744.Liking for white rice,35087,-0.0132101548582063,0.0175950190476787,-0.0476963921916566,0.021276082475244,0.452795998524862
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20745.Liking for white wine,35087,-0.000751828094235019,0.0174473719759393,-0.034948677167076,0.033445020978606,0.965629648432622
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35087,0.0380643823768411,0.01770324479778,0.0033660225731923,0.07276274218049,0.0315669613844921
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,35087,-0.00832379470703531,0.0174507045194441,-0.0425271755651457,0.0258795861510751,0.633379739002488
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,35087,0.0167658861537431,0.0185102132675239,-0.0195141318506037,0.05304590415809,0.36508127790026
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,35087,0.00939276785886318,0.0175167690749612,-0.0249400995280608,0.0437256352457872,0.591820658532174
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21001.Body mass index (BMI),52256,0.0661808522916845,0.0231072409802287,0.0208906599704362,0.111471044612933,0.00418543037572471
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21002.Weight,52264,-0.0247023931526398,0.0142902889492438,-0.0527113594931576,0.00330657318787803,0.0838893053988755
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33636,0.0049288033446878,0.00986814356859884,-0.0144127580497659,0.0242703647391415,0.617463016058288
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34498,-0.00708409356206008,0.0184296373874524,-0.0432061828414667,0.0290379957173466,0.700700557085923
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34513,-0.00407896733087442,0.0193297659517786,-0.0419653085963606,0.0338073739346117,0.832875935180989
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34514,-0.0117904592566415,0.0193724957210717,-0.049760550869942,0.0261796323566589,0.54279108315878
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,34464,-0.0353632159615429,0.0180367162560212,-0.0707151798233444,-1.1252099741399e-05,0.0499506293259964
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34445,-0.0226531376303677,0.0187562500579518,-0.0594153877439533,0.0141091124832179,0.227166373367293
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,34458,-0.0163846526288857,0.0193350244963842,-0.0542813006417988,0.0215119953840274,0.396788069414454
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,34366,0.0153046994257258,0.0190517171450666,-0.0220366661786048,0.0526460650300564,0.421806817252405
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,34421,-0.000770082567717662,0.0218176547767052,-0.0435326859300598,0.0419925207946245,0.971844178010669
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34517,0.0192639790103512,0.0194289533393247,-0.0188167695347253,0.0573447275554276,0.321461014999147
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34511,-0.0194271417849129,0.0196699042021952,-0.0579801540212156,0.0191258704513898,0.323343840528605
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34514,-0.0134186291741956,0.0226922837030214,-0.0578955052321176,0.0310582468837264,0.554312587609413
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34514,-0.00603203787621653,0.020400043585713,-0.046016123304214,0.0339520475517809,0.767474846693965
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34511,-0.00484557242995903,0.0303982788934788,-0.0644261990611774,0.0547350542012594,0.873354690691207
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34512,-0.0206118978320348,0.0223823972296429,-0.0644813964021349,0.0232576007380654,0.357125931011917
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34512,0.025132395073246,0.0566314266999345,-0.0858652012586255,0.136129991405118,0.657204804475045
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34516,-0.0174408133046971,0.0212241843072222,-0.0590402145468526,0.0241585879374584,0.411242959683176
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34515,-0.0476442153700678,0.0223492119847503,-0.0914486708601785,-0.00383975987995717,0.0330468382479349
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34249,-0.0376809154862802,0.0199157809850736,-0.0767158462170244,0.0013540152444641,0.0585187219133396
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34512,0.0301354187785974,0.0200574490985146,-0.00917718145449112,0.0694480190116859,0.133010979468019
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34515,0.0159931990172255,0.0263434624202827,-0.0356399873265286,0.0676263853609796,0.543796158702565
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34516,-0.00676196085569452,0.0194740790565493,-0.0449311558065312,0.0314072340951422,0.728426706881084
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34514,-0.0276881370078431,0.0194972917026314,-0.0659028287450006,0.0105265547293143,0.155609062340121
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),52119,0.0390407186775056,0.0116011154709678,0.0163025323544086,0.0617789050006025,0.000765767175156707
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,48429,-0.00224408433012918,0.00729396103280099,-0.0165402479544191,0.0120520792941608,0.758341198835971
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,46888,-0.0158343380009869,0.0131232428546789,-0.0415558939961575,0.0098872179941838,0.227603847464854
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22032.IPAQ activity group,45958,-0.0201043553268888,0.0130862001071418,-0.0457533075368867,0.00554459688310908,0.124479042332851
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22033.Summed days activity,46643,-0.0128917609620048,0.00690535477450032,-0.0264262563200255,0.000642734396015785,0.0619256124986485
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22034.Summed minutes activity,45958,-0.00800362939220401,0.00694585441911444,-0.0216175040536683,0.00561024526926029,0.249215277126889
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22037.MET minutes per week for walking,44919,-0.00704053616236028,0.00705657816871101,-0.0208714293730339,0.00679035704831329,0.318423717608154
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,45958,-0.00476978695608177,0.0068578915438005,-0.0182112543819308,0.00867168046976721,0.486738254959934
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,45958,-0.0145123033806611,0.0131005929292106,-0.0401894655219139,0.0111648587605917,0.267978180235764
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,44919,-0.0102207052104222,0.00718348090774278,-0.024300327789598,0.00385891736875368,0.154807421634563
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,48442,-0.00462600813530821,0.00656931789643688,-0.0175018712123245,0.00824985494170807,0.481325068622195
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X22501.Year ended full time education,31405,0.0365946979081599,0.0307947403591371,-0.0237629931957487,0.0969523890120685,0.234739098302773
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,31361,0.0429114715850398,0.0485443659732311,-0.0522354857224932,0.138058428892573,0.376746418001753
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50450,0.025581435997895,0.027179040847643,-0.0276894840634852,0.0788523560592752,0.346601267846251
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23098.Weight,51843,-0.0239197539475634,0.014394158110086,-0.052132303843332,0.00429279594820523,0.0965707076690163
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23099.Body fat percentage,51844,0.073428001911798,0.0147685105046668,0.044481721322651,0.102374282500945,6.66897418440397e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23100.Whole body fat mass,51835,0.0360954264483527,0.0141594822596018,0.00834284121953314,0.0638480116771723,0.0108022774777674
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51843,-0.0582084017032419,0.0118458408548244,-0.0814262497786977,-0.0349905536277861,8.98311997814857e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23102.Whole body water mass,51843,-0.056854471472004,0.0118876365878833,-0.0801542391842552,-0.0335547037597527,1.73893417896518e-06
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23104.Body mass index (BMI),51843,0.071398712059459,0.0234011298592394,0.0255324975353498,0.117264926583568,0.00228238126541372
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23105.Basal metabolic rate,51841,-0.0562678832979992,0.0129147613142045,-0.0815808154738401,-0.0309549511221583,1.32417514094329e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23106.Impedance of whole body,51837,0.0501887638416207,0.00968605720670391,0.031204091716481,0.0691734359667604,2.21611638996672e-07
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23107.Impedance of leg (right),51840,0.0701479975441745,0.00792521003410431,0.0546145858773301,0.085681409211019,9.16538189753887e-19
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23108.Impedance of leg (left),51839,0.0677802622876778,0.00784437383752809,0.0524052895661228,0.0831552350092329,5.89008564629199e-18
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23109.Impedance of arm (right),51830,0.0175384561329018,0.00970927376202505,-0.00149172044066728,0.0365686327064709,0.0708729025977988
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23110.Impedance of arm (left),51838,0.0149664514685103,0.00973856771612857,-0.00412114125510169,0.0340540441921223,0.124348297353094
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51839,0.18203285565728,0.0233313923429128,0.13630332666517,0.227762384649389,6.30677377495846e-15
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23112.Leg fat mass (right),51838,0.115826972231417,0.0267766196879044,0.063344797643124,0.168309146819709,1.52602744148299e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51838,-0.0860727398535125,0.0120344804578715,-0.109660321550941,-0.0624851581560844,8.75552320351014e-13
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51837,-0.0861836796388129,0.012079841867246,-0.109860169698615,-0.0625071895790107,9.95504575393372e-13
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51834,0.18539185872821,0.0240722689330324,0.138210211619466,0.232573505836953,1.39043004119879e-14
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23116.Leg fat mass (left),51834,0.115080363955026,0.026880916260624,0.0623937680842029,0.167766959825849,1.86589218832299e-05
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51832,-0.0819562372578591,0.0123414233231494,-0.106145426971232,-0.0577670475444864,3.17941748318935e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51831,-0.0813076415788253,0.0123878393944783,-0.105587806792003,-0.0570274763656479,5.34964963111179e-11
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51831,0.057983315327103,0.0163986775159718,0.0258419073957982,0.0901247232584078,0.00040713165258997
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23120.Arm fat mass (right),51827,0.0265780001143756,0.0147803660845783,-0.00239151741139789,0.0555475176401492,0.0721569135506854
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51829,-0.0355479159870311,0.0115217249136093,-0.0581304968177054,-0.0129653351563568,0.00203553304767002
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51828,-0.0379088467621625,0.0115211489309489,-0.0604902986668224,-0.0153273948575026,0.00100182022904353
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51825,0.0525815075884547,0.0183853132018272,0.0165462937128734,0.0886167214640361,0.00423996865046121
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23124.Arm fat mass (left),51824,0.034548945645598,0.0151477077917831,0.00485943837370303,0.0642384529174929,0.0225677234781517
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51824,-0.0270033646946098,0.0124186348944824,-0.0513438890877952,-0.0026628403014244,0.0296819221181815
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51822,-0.0241185459454016,0.0124390526813115,-0.048499089200772,0.000261997309968873,0.0525192120328833
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23127.Trunk fat percentage,51820,0.0303892170285587,0.00934051258461737,0.0120818123627087,0.0486966216944087,0.00114136966361223
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23128.Trunk fat mass,51816,0.0193824900895547,0.0107665129226196,-0.00171987523877983,0.0404848554178892,0.0718310784259421
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51810,-0.0416928830253923,0.0110644919297047,-0.0633792872076135,-0.020006478843171,0.000164793860061799
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X23130.Trunk predicted mass,51807,-0.0402614783686284,0.0110828797541183,-0.0619839226867002,-0.0185390340505565,0.000280914947151747
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,40422,0.0768849562257735,0.0081945660853194,0.0608236066985475,0.0929463057529995,7.29501426585062e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40422,0.0844561990730601,0.00792558519482565,0.0689220520912018,0.0999903460549184,2.00242963530572e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40422,0.0854628845012215,0.00791459809790236,0.0699502722293329,0.10097549677311,4.35713032653447e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,40422,0.0947539114900539,0.00775548759642124,0.0795531558010683,0.10995466717904,3.55482771771113e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40422,0.0713311960094199,0.00793846726880182,0.0557718001625683,0.0868905918562714,2.85817946686564e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,40422,0.0802483834202465,0.00793130293100435,0.064703029675478,0.0957937371650151,5.43396985465535e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,40422,-0.00680276145567855,0.00915837179344555,-0.0247531701708318,0.0111476472594747,0.457618799554327
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,40422,0.114746854494888,0.00838376888300014,0.0983146674842082,0.131179041505569,2.11259749949175e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,40422,0.109107989825267,0.00839221964235792,0.0926592393262458,0.125556740324289,1.89042105529931e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,40422,0.120975774847732,0.008347113781565,0.104615431835865,0.1373361178596,2.67295282491535e-47
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,40422,0.105912324374735,0.00790749668213797,0.0904136308777449,0.121411017871726,1.08816690506457e-40
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40422,0.0954249325386195,0.00833698627305111,0.0790844394434393,0.1117654256338,3.23090038410057e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,40422,0.105422780130585,0.00798024167890595,0.0897815064399297,0.121064053821241,1.23218764890154e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,40422,0.0798219595901281,0.00787340450112881,0.0643900867679156,0.0952538324123405,4.42379612325859e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,40422,0.0314163577780912,0.00888518931841675,0.0140013867139944,0.0488313288421881,0.000407675134439961
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,40422,0.0743602596839385,0.00822243060614323,0.0582442956958978,0.0904762236719792,1.68719313997316e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40422,0.0884242597504443,0.00771362140176884,0.0733055618029774,0.103542957697911,2.64692435787926e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40422,0.0868095888392378,0.00791101563388491,0.0713039981968234,0.102315179481652,6.46507032005827e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40422,-0.0123331674237271,0.00909606207409718,-0.0301614490889575,0.0054951142415034,0.175156566296165
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,40422,0.0812879380736895,0.00812283382356744,0.0653671837794973,0.0972086923678816,1.65973990201407e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40422,0.10234552624178,0.00788839068659075,0.0868842804960624,0.117806771987498,2.67632537986938e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,40422,0.0598731598380091,0.00800830737312781,0.0441768773866786,0.0755694422893396,8.03565834280992e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,40422,0.0116907015374103,0.00920114203407393,-0.00634353684937457,0.0297249399241952,0.203899922502892
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40422,0.10533699586981,0.00814306414332934,0.0893765901488847,0.121297401590736,4.3915118361874e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,40422,0.110407536235185,0.00813956416124775,0.0944539904791396,0.126361081991231,1.10939413475167e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,40422,0.084747044432534,0.00791295370236743,0.0692376551758939,0.100256433689174,1.12652742404453e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,40422,0.0231405358217611,0.00899294968264506,0.00551435444377673,0.0407667171997454,0.0100856325036669
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40422,0.0738734219645739,0.00839333766100833,0.0574224801489976,0.0903243637801502,1.4869329813872e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,40422,0.101924287085557,0.00786453630534088,0.0865097959270887,0.117338778244025,3.21506314431228e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,40422,0.0760800423897553,0.00785706198112278,0.0606802009067546,0.0914798838727559,4.0956515363867e-22
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,40422,0.0635552841294163,0.00841632126563072,0.0470592944487801,0.0800512738100525,4.53724053750893e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40422,0.0991867814367643,0.00886205439909029,0.0818171548145473,0.116556408058981,5.70065438978111e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40422,-0.0526824607822967,0.00813887931349362,-0.0686346642367442,-0.0367302573278492,9.8916927493786e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40422,-0.0826044260375355,0.00960888520251803,-0.101437841034471,-0.0637710110406002,8.95682736155483e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,40407,0.0947313817210793,0.00838318419927716,0.078300340690496,0.111162422751662,1.69536641863319e-29
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40407,0.0901036339731001,0.0088983111260032,0.0726629441661338,0.107544323780066,5.01114232375307e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23436.Total Cholines,40407,0.0907047170749646,0.00840492131279977,0.0742310713018771,0.107178362848052,4.66380961985126e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,40407,0.0787505832078963,0.00841903163804147,0.062249281197335,0.0952518852184576,9.54786030494412e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,40406,0.0798030290407428,0.00845764613193962,0.0632260426221411,0.0963800154593444,4.41162891186862e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,40422,0.0784914347848001,0.00785245909791568,0.0631006149528854,0.0938822546167149,1.86392220152145e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,40422,0.0431062383728563,0.0087104811931581,0.0260336952342664,0.0601787815114462,7.54415008396405e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40422,0.0463328046028882,0.00793988582427112,0.0307706283873168,0.0618949808184596,5.4684464586497e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,40407,0.127804079883843,0.00837526643930016,0.111388557662815,0.144219602104871,3.31539189103619e-52
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,40407,-0.0800486048804041,0.00883739824395202,-0.09736990543855,-0.0627273043222581,1.48052145139967e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40407,0.0248099664144933,0.00826757517263049,0.00860551907613757,0.0410144137528491,0.00269620401216793
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40407,0.0982295955259655,0.00811608885652236,0.0823220613671817,0.114137129684749,1.42749101363338e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40407,0.0902708172507194,0.00819279822522344,0.0742129327292815,0.106328701772157,3.93888677969269e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40407,0.139629284675658,0.00859230053617023,0.122788375624765,0.156470193726552,6.58167432906878e-59
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,40407,0.136310033563864,0.00854716598338034,0.119557588236438,0.153062478891289,8.08607532605825e-57
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,40407,0.0947700355157635,0.00804081061523044,0.0790100467099118,0.110530024321615,6.24292268457085e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,40407,-0.000321791636039544,0.00869703086735129,-0.0173679721360481,0.016724388863969,0.970485331670376
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40407,-0.0406803265573902,0.00825966548485877,-0.0568692709077134,-0.024491382207067,8.51269288603902e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40407,-0.109658660661771,0.0091908465585099,-0.12767271991645,-0.0916446014070916,1.11974507976542e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40407,-0.133492275302398,0.00921643257686604,-0.151556483153055,-0.11542806745174,3.04247154895034e-47
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40407,0.115012808419831,0.00908943341119622,0.0971975189338866,0.132828097905776,1.60338869236909e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40407,0.0788010764282941,0.00859338957287721,0.0619580328654548,0.0956441199911335,5.29792538853715e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40407,-0.0376811243147698,0.00887723978892504,-0.0550805143010629,-0.0202817343284767,2.20133812067442e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40407,-0.0822973551295616,0.0087904685434841,-0.0995266734747904,-0.0650680367843328,8.83579028032298e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40407,-0.129481670398616,0.00917867600473858,-0.147471875367904,-0.111491465429329,6.42196085281468e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40405,0.0140552141590813,0.00822757193409039,-0.0020708268317359,0.0301812551498984,0.087598949647742
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23460.Alanine,40415,0.0861370813397091,0.00784909094192868,0.0707528630935289,0.101521299585889,6.40263936410727e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23461.Glutamine,40374,-0.137013975654797,0.00786503987791189,-0.152429453815505,-0.12159849749409,2.42216468546988e-67
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23462.Glycine,40401,0.0298357039693029,0.00761734323398832,0.0149057112306858,0.0447656967079201,9.01013541107257e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23463.Histidine,40401,0.0176475261422467,0.00776059673514674,0.00243675654135907,0.0328582957431343,0.0229797620850549
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40412,0.0590774069362607,0.00791797726092696,0.0435581715048439,0.0745966423676776,9.01658984407715e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23465.Isoleucine,40418,0.034887173722146,0.00777880637696696,0.0196407132232908,0.0501336342210012,7.34565398467163e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23466.Leucine,40419,0.05287301593808,0.00792065731069403,0.0373485276091197,0.0683975042670403,2.5479940898366e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23467.Valine,40412,0.0672785574245998,0.00798336285954871,0.0516311662198843,0.0829259486293153,3.83420037712243e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23468.Phenylalanine,40418,0.027343370381228,0.00773702329389198,0.0121788047251997,0.0425079360372562,0.000410331701617342
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23469.Tyrosine,40402,0.0370493271845593,0.00778958808243709,0.0217817345429826,0.052316919826136,1.98935178156862e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23470.Glucose,40390,-0.0544457205075524,0.00821914023300047,-0.0705552353642333,-0.0383362056508714,3.60164089770576e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23471.Lactate,40390,0.229151712446931,0.00750327861699588,0.214445286357619,0.243858138536242,3.97613543654529e-199
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23472.Pyruvate,40375,0.11601934343047,0.00791661133647795,0.100502785210973,0.131535901649967,2.57604631431602e-48
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23473.Citrate,40420,0.0335587852313757,0.00792029296613706,0.0180350110177471,0.0490825594450043,2.27732207364664e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,40222,0.0497285272092151,0.00745320588192619,0.0351202436806397,0.0643368107377904,2.60566657123592e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23475.Acetate,40408,-0.123596713859367,0.00798391365317314,-0.139245184619586,-0.107948243099147,1.14979306816831e-53
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23476.Acetoacetate,40421,-0.0127945299339401,0.00773601212659015,-0.0279571137020568,0.00236805383417655,0.0981690771097084
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23477.Acetone,40421,-0.0601539554028768,0.0077465191843636,-0.0753371330042295,-0.0449707778015241,8.63802806178333e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23478.Creatinine,39939,0.0301542020293624,0.00912399184204605,0.0122711780189521,0.0480372260397726,0.000952140926702581
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23479.Albumin,40420,0.0538758949145451,0.00799926737524891,0.0381973308590572,0.0695544589700329,1.69403942940731e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,40422,0.233040083803642,0.00833111760406152,0.216711093299681,0.249369074307602,3.89066402607061e-168
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40422,0.10248329067568,0.00847798114283122,0.0858664476357304,0.119100133715629,1.70810071779878e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40422,0.0981970848947445,0.00848214981532525,0.081572071256707,0.114822098532782,7.1662233146494e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40422,0.102207443482489,0.00834539863419937,0.0858504621594586,0.11856442480552,2.48041840312469e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40422,0.109883813150349,0.00832786827919707,0.0935611913231231,0.126206434977576,1.51563682362714e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40422,0.111604069213922,0.00827702210179906,0.0953811058943957,0.127827032533448,3.28290557424912e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40422,0.105987275397899,0.00837179980347105,0.0895785477830956,0.122396003012702,1.47533327158318e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40422,0.0883085381436867,0.00855652089640053,0.0715377571867417,0.105079319100632,6.80815601065827e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40422,0.109808936862995,0.00831421765896305,0.0935130702514274,0.126104803474563,1.28351895296491e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40422,0.107766497400382,0.00833213267348176,0.0914355173603574,0.124097477440406,4.50318931397226e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40422,0.104998738113363,0.00826027512428425,0.0888085988697657,0.12118887735696,7.72002875340982e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40422,0.103492364303892,0.00802877781773061,0.0877559597811399,0.119228768826644,7.89390504664168e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40422,0.0999204956855045,0.00786694203031247,0.0845012893060921,0.115339702064917,8.7588237338342e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40422,0.103291083296754,0.00820467521896027,0.0872099198675917,0.119372246725916,3.59158205894788e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40422,0.105999155735685,0.00843077066839912,0.0894748452256228,0.122523466245747,4.41161169638183e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40422,0.108037982488828,0.00823554130190931,0.0918963215370857,0.12417964344057,4.10978533945531e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40422,0.105302706123416,0.00822228887548283,0.0891870199274694,0.121418392319362,2.28835631648189e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40422,0.105900625814038,0.00817751623773857,0.0898726939880703,0.121928557640006,3.64666248726903e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40422,0.103732764318982,0.00794518080943674,0.0881602099324861,0.119305318705478,9.26809721063232e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40422,0.0963640236805107,0.0077598808496537,0.0811546572151894,0.111573390145832,3.02694371933238e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40422,0.109088003868927,0.00814750836412779,0.0931188874752365,0.125057120262617,1.15981488862428e-40
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40422,0.101496695587097,0.00835374300103138,0.0851233593050753,0.117870031869118,8.10404418159887e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40422,0.0942821061776128,0.00782002924637822,0.0789548488547115,0.109609363500514,2.50166552138308e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40422,0.100254721574327,0.00789958128399717,0.084771542257693,0.115737900890962,9.96092746477341e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40422,0.0914097694183797,0.00780201486590551,0.0761178202812049,0.106701718555554,1.41821595730338e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40422,0.0672665497635568,0.00787395455306789,0.0518335988395437,0.0826995006875698,1.42540674164482e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40422,0.0510510331825498,0.00801606639733549,0.0353395430437722,0.0667625233213274,1.9598885463927e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40422,0.0841288455906501,0.00778553798515066,0.0688691911397549,0.0993885000415454,4.01112891596689e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40422,0.108978296816357,0.00819223430921086,0.0929215175703035,0.12503507606241,3.65521629641044e-40
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40422,0.10301583134155,0.00787245309760932,0.087585823270236,0.118445839412865,6.31075906064954e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40422,0.106175628649827,0.00782665288476297,0.0908353889956915,0.121515868303962,1.08572953011883e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40422,0.0967314608729039,0.00773949674053619,0.081562047261453,0.111900874484355,1.11844092727069e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40422,0.0898272234656615,0.00765628994678933,0.0748208951699544,0.104833551761369,1.1718370797746e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40422,0.0911362654706143,0.00761080712241087,0.076219083510689,0.10605344743054,6.67871399634685e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40422,0.0855322873285915,0.00775957052924366,0.0703235290912739,0.100741045565909,3.7474529709392e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40422,0.105996104316397,0.00812016177459166,0.0900805872381972,0.121911621394597,9.58819241324915e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40422,0.0849909590647211,0.00793582458772679,0.0694367428727766,0.100545175256666,1.12809744665772e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40422,0.0827486705342063,0.00793330732533788,0.0671993881765441,0.0982979528918686,2.17032128795048e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40422,0.0780036191671364,0.00792278040909485,0.0624749695653105,0.0935322687689623,8.32536582164622e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40422,0.0666210214586285,0.00808383197448933,0.0507767107886295,0.0824653321286276,1.83504702459189e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40422,0.0614448090864049,0.00814548286912514,0.0454796626629197,0.0774099555098902,4.82395082231929e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40422,0.0760858401173706,0.00795803710918877,0.0604880873833606,0.0916835928513806,1.33388062201302e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40422,0.0998556459179639,0.00806830026330401,0.084041777401888,0.11566951443404,5.08286066304739e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,40422,0.0616380744866956,0.00796975206377121,0.046017360441704,0.0772587885316872,1.1041071022844e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,40422,0.0673449062067652,0.00818313705587249,0.0513059575772551,0.0833838548362753,2.02009689456009e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,40422,0.0643798125575689,0.00821252357675861,0.0482832663471221,0.0804763587680158,4.8179290575061e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,40422,0.0584449246208646,0.00819537205233594,0.0423819953982862,0.074507853843443,1.03571616918449e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40422,0.0581897134582264,0.00817524015261733,0.0421662427590964,0.0742131841573563,1.14330221181059e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,40422,0.0573844407561768,0.00824429056940198,0.0412256312401489,0.0735432502722047,3.52243181094685e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,40422,0.102916520631028,0.00818080921974903,0.08688213456032,0.118950906701736,4.02360158410749e-36
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40422,0.0643027112238065,0.00790085572090239,0.0488170340108379,0.0797883884367752,4.28743220304071e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,40422,0.0798008448610784,0.0079780231099305,0.0641639195656146,0.0954377701565421,1.74087241868792e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,40422,0.0793390740483022,0.00794017602050584,0.0637763290481107,0.0949018190484936,1.93385397092289e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,40422,0.0736679611556282,0.00800502358301703,0.0579781149329149,0.0893578073783416,3.91358588468134e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40422,0.0785284271330481,0.0079695212340125,0.0629081655143836,0.0941486887517126,7.68385114626055e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40422,0.058113740807745,0.00809548602643264,0.042246588195937,0.073980893419553,7.35633194952021e-13
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,40422,0.116727850498696,0.00828345121559575,0.100492286116128,0.132963414881264,7.92843924436453e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40422,0.0945854937677431,0.00782726548393378,0.0792440534192329,0.109926934116253,1.79395237361426e-33
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40422,0.0958169730799075,0.00785826548324256,0.0804147727327521,0.111219173427063,4.79089845823227e-34
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40422,0.0889450377059884,0.00780729626406528,0.0736427370284204,0.104247338383556,5.94424775013568e-30
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40422,0.0930380556371684,0.00785934476134483,0.0776337399049326,0.108442371369404,3.38984832990144e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40422,0.100656377523258,0.00788106182611987,0.0852094963440631,0.116103258702453,3.57603165785958e-37
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40422,0.0681841593610049,0.00787949534101919,0.0527403484926073,0.0836279702294025,5.47016936367645e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40422,0.124206356135445,0.00840013404638827,0.107742093404524,0.140670618866366,3.7984449866144e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40422,0.0810385332915982,0.0078119573008981,0.065727096981838,0.0963499696013585,3.92733817428883e-25
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,40422,0.0780021072401523,0.00788222216279183,0.0625529518010803,0.0934512626792243,5.0489769454031e-23
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,40422,0.0517924112739389,0.00785413122482953,0.036398314073273,0.0671865084746048,4.40705498336678e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,40422,0.0797462740320928,0.00786032634202892,0.0643400344017161,0.0951525136624694,4.10971098880886e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40422,0.0918058968222555,0.00790264990334493,0.0763167030116994,0.107295090632812,4.49860426432846e-31
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40422,0.0436702891846446,0.00783773372049625,0.0283083310924719,0.0590322472768172,2.56193113021391e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,40422,0.121367051942908,0.00847181058952211,0.104762303187445,0.137971800698371,2.91370672138123e-46
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40422,-0.0584646040893225,0.00913033802413332,-0.0763600666166238,-0.0405691415620212,1.56265307813363e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40422,-0.0775821049037349,0.00918320157758822,-0.0955811799958078,-0.059583029811662,3.20845942916096e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40422,-0.0820547557059194,0.0091895888754262,-0.100066349901755,-0.0640431615100841,4.75445789006908e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40422,-0.0806577800573357,0.00911687921200091,-0.0985268633128575,-0.062788696801814,9.90892531009474e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40422,-0.0810919342794344,0.00926334792572243,-0.0992480962138503,-0.0629357723450184,2.26094165892158e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40422,-0.073844251845392,0.00849854778121757,-0.0905014054965785,-0.0571870981942056,4.00443308182028e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40422,0.07474414837105,0.00822377539694371,0.0586255485930403,0.0908627481490596,1.1168517785267e-19
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40422,-0.0555631349968308,0.00966642472652812,-0.074509327460826,-0.0366169425328357,9.19238278304652e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,40422,-0.0538573529363089,0.00961704763491543,-0.0727067663007432,-0.0350079395718747,2.176379691638e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,40422,-0.0441017141515441,0.00949635590249344,-0.0627145717204312,-0.025488856582657,3.44339231841928e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,40422,-0.0718178872252215,0.00960631698177592,-0.0906462685095023,-0.0529895059409407,8.05217056960294e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40422,-0.0753741904414594,0.0095779623269291,-0.0941469966022405,-0.0566013842806784,3.7863083720744e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40422,-0.0580360983696143,0.00960074619634911,-0.0768535609144586,-0.03921863582477,1.52774306089409e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,40422,0.0646778575658042,0.00813752916815024,0.0487283003962297,0.0806274147353787,2.01972983296775e-15
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40422,0.0415535556984945,0.00863991986913014,0.0246193127549994,0.0584877986419896,1.52700694563754e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40422,0.0503250375999941,0.00856154433543323,0.033544410702545,0.0671056644974433,4.2344314832124e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40422,0.0593014132143002,0.0085056031970834,0.0426304309480167,0.0759723954805837,3.24610894095541e-12
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40422,0.0236928276424482,0.00867063399491553,0.00669838501241378,0.0406872702724827,0.00629177408080624
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40422,0.0199109771763205,0.00862798907109904,0.00300011859696642,0.0368218357556747,0.0210274714935142
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40422,0.0375677936312071,0.00877880901232243,0.0203613279670551,0.054774259295359,1.88512728351635e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40422,0.106513514135544,0.00783530321126253,0.0911563198414694,0.121870708429619,7.42568842656427e-42
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40422,0.104704672690583,0.00774386222619177,0.0895267027272472,0.119882642653919,1.98756415059217e-41
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,40422,0.117642177685185,0.00781789127445486,0.102319110787253,0.132965244583116,7.9586423775949e-51
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,40422,0.115847236761172,0.00790299812912563,0.100357360428086,0.131337113094258,2.44433876899205e-48
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,40422,0.0957937073541213,0.00776760637741248,0.0805691988543928,0.11101821585385,8.72090866347911e-35
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40422,0.0852792445877318,0.00768991792000769,0.0702070054645167,0.100351483710947,1.78734785007216e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40422,0.113313726855793,0.00803853506171222,0.0975581981348368,0.129069255576749,7.43191686381748e-45
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,40422,0.121507146762795,0.00807343254441401,0.105683218975743,0.137331074549846,7.6753876054008e-51
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39541,0.0481944570307122,0.00741906486578417,0.0336530898937752,0.0627358241676492,8.50501892620183e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39541,0.01611948816808,0.00778801045964526,0.000854987667175264,0.0313839886689847,0.0384896892131345
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39541,0.0256267126307141,0.00759343445748104,0.0107435810940513,0.0405098441673769,0.000740416243153862
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39541,-0.00633374815457809,0.00793222789949101,-0.0218809148375805,0.00921341852842429,0.424602892902619
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39541,-0.0305692527997319,0.00754702854169754,-0.0453614287414591,-0.0157770768580048,5.13635235598019e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40186,0.025690493686483,0.00730510267173252,0.0113724924498873,0.0400084949230788,0.000438033627573354
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40186,-0.0511805440609789,0.00827214422819353,-0.0673939467482383,-0.0349671413737196,6.27996381833709e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40186,-0.0500869771274414,0.00829227691876575,-0.0663398398882222,-0.0338341143666605,1.57392397499622e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40186,-0.0449941275988322,0.00784544414040641,-0.0603711981140288,-0.0296170570836357,9.92652406313174e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40186,0.0342687350332901,0.00794585876282996,0.0186948518581433,0.0498426182084368,1.62196989104331e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40417,0.0737230097851516,0.00775029079552961,0.0585324398259136,0.0889135797443897,2.12518598192904e-21
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40417,0.00223578133163235,0.00766682099200318,-0.0127911878126939,0.0172627504759586,0.770582666948774
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40417,-0.0196382759877743,0.00804660488545694,-0.0354096215632699,-0.00386693041227869,0.0146750326567376
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40417,0.0485000506422997,0.00737195267667157,0.0340510233960234,0.062949077888576,4.88363060096446e-11
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40417,-0.0314320815648832,0.00723937595315755,-0.045621258433072,-0.0172429046966944,1.42176257699628e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40422,-0.00826632066831338,0.00810103860647763,-0.0241443563370095,0.00761171500038278,0.307553029555901
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40422,-0.0473057469557196,0.0084638092238183,-0.0638948130344035,-0.0307166808770357,2.31876359251609e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40422,-0.0537534810981213,0.00852622646643469,-0.0704648849723333,-0.0370420772239093,2.9674320766976e-10
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40422,-0.0272566142698209,0.00828167485257247,-0.043488696980863,-0.0110245315587789,0.000999787546675726
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40422,0.0390164266286702,0.00840500704951859,0.0225426128116138,0.0554902404457266,3.47721475332534e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40422,-0.0323011609896427,0.00824161644753569,-0.0484547292268127,-0.0161475927524728,8.91861514704654e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40422,-0.0162342768117154,0.00806283353922143,-0.0320374305485894,-0.000431123074841423,0.0440819075709045
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40422,-0.00179836793386231,0.00783891305906504,-0.0171626375296298,0.0135659016619052,0.818548950381033
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40422,-0.0351846139312416,0.00826773914559945,-0.0513893826566166,-0.0189798452058667,2.09630147707618e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40422,0.0211631585222514,0.00812957495084723,0.00522919161859086,0.037097125425912,0.00924351966873806
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40422,-0.0264483760430055,0.00827636928985315,-0.0426700598511177,-0.0102266922348933,0.00139787789304721
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40422,-0.0356159041641998,0.00859365276776299,-0.0524594635890152,-0.0187723447393843,3.42396767235128e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40422,-0.0364385519346853,0.00864826659435446,-0.0533891544596201,-0.0194879494097506,2.52943031665999e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40422,-0.0212125532214711,0.00839177818655321,-0.0376604384671154,-0.0047646679758268,0.0114882483310928
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40422,0.0478823899639402,0.00857537481183723,0.0310746553327392,0.0646901245951411,2.39279372433088e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40422,-0.0326256152052199,0.00771584823908672,-0.0477486777538298,-0.0175025526566099,2.36679335908525e-05
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40422,-0.015365611124279,0.00816997346088182,-0.0313787591076074,0.000647536859049317,0.060025222268443
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40422,-0.0123777477555642,0.0081384015963634,-0.0283290148844365,0.00357351937330808,0.128303104533903
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40422,-0.0203345283050429,0.00840425832439979,-0.0368068746208665,-0.00386218198921929,0.0155507925440759
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40422,0.037360577097951,0.00844223468271435,0.0208137971198308,0.0539073570760711,9.68847178139088e-06
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40422,-0.0111877305497672,0.00769484231534474,-0.0262696214878429,0.00389416038830852,0.145986502018308
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40422,-0.0301226530592921,0.00846144113042966,-0.0467070776749342,-0.01353822844365,0.000371944888135888
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40422,0.029119634100302,0.00779574015603596,0.0138399833944715,0.0443992848061325,0.00018812401323764
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40422,-0.0741430307205625,0.00843419598764882,-0.0906740548563542,-0.0576120065847708,1.63444941032443e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40422,0.0306892650387939,0.00841464034882138,0.014196569955104,0.0471819601224838,0.000266031779093135
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40422,-0.0670064315975754,0.00759978830484196,-0.0819020166750656,-0.0521108465200851,1.29642238633359e-18
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40422,0.02432622507724,0.00783833096438183,0.00896309638705159,0.0396893537674284,0.00191583126061431
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40422,0.0869105052397136,0.00791550251972573,0.0713961203010512,0.102424890178376,6.01769002875148e-28
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40422,-0.0920969575625723,0.00857984812744323,-0.108913459892361,-0.0752804552327836,8.68875071059907e-27
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40422,0.0181132727623089,0.00812897931860267,0.00218047329784765,0.0340460722267701,0.0258787454720971
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40422,-0.124301587569885,0.00771600838937727,-0.139424964013065,-0.109178211126706,6.2516532418789e-58
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40422,0.0661976852203548,0.00786514079049736,0.05078200927098,0.0816133611697297,4.20094250278212e-17
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40422,0.115568908580596,0.00779654513780364,0.100287680110501,0.130850137050691,2.21197346006732e-49
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40422,-0.0685019885790757,0.00840316827566147,-0.0849721983993722,-0.0520317787587792,3.84535855434078e-16
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40422,0.0631058092000527,0.00830984645408551,0.0468185101500451,0.0793931082500603,3.27045546878549e-14
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40420,-0.0899389921416222,0.00893930022235688,-0.107460020577442,-0.0724179637058028,9.66184053321278e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40420,0.0188807811383604,0.00894668699067404,0.00134527463663931,0.0364162876400815,0.0348423801171511
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40420,-0.00297905961193057,0.00897128571737893,-0.0205627796179933,0.0146046603941321,0.739843726717047
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40420,0.0531250486255652,0.00949907081617468,0.0345068698258628,0.0717432274252676,2.27286664495316e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40420,0.126366086190812,0.00887287135634597,0.108975258332374,0.14375691404925,9.60173676631452e-46
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40422,0.0993721228036669,0.00927104170508521,0.0812008810616998,0.117543364545634,1.02682780783973e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40422,-0.119802644372873,0.00920120416941082,-0.137837004544918,-0.101768284200828,1.47363436952844e-38
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40422,-0.121566704723531,0.00929520353411503,-0.139785303650397,-0.103348105796666,6.92849711066614e-39
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40422,-0.0546289437018321,0.00896329513588368,-0.0721970021681642,-0.0370608852355001,1.12134679422887e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40422,0.105111189192342,0.00893730949945226,0.0875940625734155,0.122628315811268,8.39163643088207e-32
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40422,0.053381118413155,0.00875452329448272,0.0362222527559689,0.0705399840703411,1.10187505899496e-09
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40422,-0.0784104728990535,0.00852147033395872,-0.0951125547536126,-0.0617083910444944,3.95720698959078e-20
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40422,-0.0852418835131667,0.0084675111219238,-0.101838205312137,-0.0686455617141961,9.10677375017886e-24
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40422,-0.00977313392605704,0.00918114822609352,-0.0277681844492003,0.00822191659708625,0.287128130790133
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40422,0.087757550170753,0.00828769910087943,0.0715136599330294,0.104001440408477,4.09572614950831e-26
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40422,-0.0110396908551127,0.00814334271400594,-0.0270006425745643,0.00492126086433896,0.175223146411512
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40422,-0.0458274613036415,0.00814973535440201,-0.0618009425982694,-0.0298539800090135,1.90608990445798e-08
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40422,-0.0402923395777646,0.00817883948748848,-0.0563228649732421,-0.0242618141822872,8.45912070049861e-07
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40422,-0.0115271408195799,0.00831923597918572,-0.0278328433387839,0.00477856169962412,0.165888154460187
PLA2G4A,Cytosolic phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40422,0.0844759411955434,0.00828204134544811,0.0682431401584651,0.100708742232622,2.35727759790516e-24
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51958,-0.00297932783881167,0.00677924615299523,-0.0162666502986823,0.010307994621059,0.660318853962106
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51958,-0.00867490822061532,0.00664255526617635,-0.021694316542321,0.00434450010109033,0.191577248718696
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50083,0.00118484296793946,0.00634891371503726,-0.0112590279135336,0.0136287138494125,0.851958988198667
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50083,-0.0134210592028003,0.00690830123967381,-0.0269613296325609,0.000119211226960406,0.0520580611105208
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50083,-0.00265769043990695,0.00678634500632867,-0.0159589266523111,0.0106435457724973,0.695339867224301
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50083,-0.00319387201653757,0.00621504743952568,-0.0153753649980079,0.00898762096493276,0.607330934643912
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51958,-0.033007070747305,0.0256656949923284,-0.0833118329322686,0.0172976914376586,0.198440467001335
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51958,-0.00511729126414486,0.00592010246969532,-0.0167206921047477,0.00648610957645798,0.387379933801315
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51958,0.000415300132381402,0.00593249577044128,-0.0112123915776835,0.0120429918424463,0.944190756938466
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51958,-0.00774218940346452,0.0060373788169578,-0.0195754518847018,0.00409107307777276,0.199721603302713
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51958,-0.0279844872563408,0.0178772143792894,-0.0630238274397481,0.00705485292706646,0.117507260789302
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51958,-0.0234107460528231,0.0173218333418259,-0.0573615394028019,0.0105400472971557,0.17654110717241
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51958,0.0105823151669987,0.00673600057053764,-0.00262024595125509,0.0237848762852525,0.116192141669134
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51958,0.00488478166531879,0.00672197184281866,-0.0082902831466058,0.0180598464772434,0.467422798836385
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51958,0.0110959585276095,0.00665619824086493,-0.00195019002448579,0.0241421070797047,0.0955235174318163
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51892,0.036698943965648,0.00655788467099228,0.0238454900105031,0.0495523979207929,2.21246921165761e-08
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51958,-0.0125711516849751,0.00596857955185016,-0.0242695676066014,-0.000872735763348743,0.0351941359486023
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51958,-0.0124941075670706,0.00596787531226101,-0.0241911431791022,-0.000797071955039023,0.0363082892705257
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51958,-0.0126037156082531,0.00596845523151523,-0.0243018878620229,-0.000905543354483212,0.0347193314262002
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51958,-0.0125420549063012,0.00596786063257896,-0.0242390617461559,-0.000845048066446398,0.0355974158987958
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51958,-0.0125392824486182,0.00596786463084509,-0.0242362971250746,-0.000842267772161827,0.0356382922509317
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48995,-0.000684400971616565,0.00694916770686243,-0.0143047696770669,0.0129359677338338,0.921546593759163
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48995,-0.00546670945028021,0.00633542672605234,-0.0178841458333428,0.00695072693278237,0.388212188766198
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",48995,-0.0144817389113817,0.0062223052293442,-0.0266774571608963,-0.00228602066186702,0.0199525393259115
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48995,0.00502192789411287,0.00654654529789167,-0.00780930088975481,0.0178531566779806,0.44302281201077
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48995,-0.00657522812139636,0.00638213622677837,-0.019084215125882,0.00593375888308923,0.302900443118296
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",48995,-0.00657600368242382,0.00625597052476599,-0.0188377059109652,0.00568569854611752,0.293197096961438
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52119,-0.0121821363018756,0.00662240442469513,-0.025162048974278,0.000797776370526849,0.0658474291746982
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52119,-0.0105129823088493,0.00624337125066156,-0.0227499899601459,0.00172402534244739,0.092219414707801
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,52119,0.041559449763223,0.00596531391625335,0.0298674344873664,0.0532514650390796,3.31367979834373e-12
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35694,0.00877858668240795,0.019259961972764,-0.0289709387842095,0.0465281121490254,0.648546491363461
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,45620,0.00214690401331123,0.0136603789211471,-0.0246274386721371,0.0289212466987595,0.875118008842611
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),51457,0.0176706262598756,0.0116632812515045,-0.00518940499307332,0.0405306575128244,0.129767712467081
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2734.Number of live births,52290,-0.00507810109640965,0.0112168534054254,-0.0270631337710435,0.0169069315782242,0.650753441464841
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2744.Birth weight of first child,46521,-0.027435199310863,0.0124673590409187,-0.0518712230310637,-0.00299917559066229,0.0277773556535289
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2754.Age at first live birth,43247,-0.010969898635332,0.00755335285322187,-0.0257744702276469,0.00383467295698289,0.146428855516205
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2764.Age at last live birth,43195,-0.00556249555594621,0.00729825879140203,-0.0198670827870942,0.00874209167520176,0.445969639547735
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,45812,-0.00314000781120624,0.0082338097715957,-0.0192782749635338,0.0129982593411213,0.702943344387918
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,43820,0.000700640549046668,0.00713288027994469,-0.0132798047996449,0.0146810858977383,0.921753157919333
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,30123,0.0140449749131599,0.0136959046378707,-0.0127989981770666,0.0408889480033865,0.305177100765121
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35625,0.0184375078042301,0.0205636120854758,-0.0218671718833025,0.0587421874917627,0.369947222890362
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35617,0.0206048644887119,0.0223595800725479,-0.023219912453482,0.0644296414309058,0.356797419480398
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35656,0.0124634179756735,0.0244108693562173,-0.0353818859625123,0.0603087219138594,0.609663383817673
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35611,0.0358473406045737,0.0234214076395392,-0.0100586183689232,0.0817532995780706,0.125912111783143
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,35668,-0.0109519942007343,0.0206219109904784,-0.051370939742072,0.0294669513406033,0.595370175401646
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,35697,0.0274530779387382,0.0223632089132123,-0.016378811531158,0.0712849674086344,0.219622820612886
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28741.Difficulty learning a new task,35587,0.0214014970457215,0.0248677662480739,-0.0273393248005033,0.0701423188919463,0.389470331481823
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,35306,0.0267646701584722,0.0261895380992429,-0.0245668245160439,0.0780961648329884,0.30682243852614
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35620,0.0469843819788984,0.0218898247949771,0.00408032538074331,0.0898884385770535,0.0318623363573834
PLA2G4A,Cytosolic phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35691,-0.0308671474055245,0.0321748401331121,-0.0939298340664242,0.0321955392553751,0.337399739688596
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,30093,0.00190005355964665,0.025822966629041,-0.0487129610332736,0.0525130681525669,0.941347204970986
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,30134,0.0247487300777315,0.0141009640742001,-0.00288915950770076,0.0523866196631638,0.0792945294123876
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34535,-0.0281898752856766,0.0197912923110427,-0.0669808082153203,0.0106010576439671,0.154373962767102
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34535,0.0397134817867097,0.0210886202359002,-0.00162021387565476,0.0810471774490741,0.0597059328767387
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34535,-0.0707180012951945,0.0702544076842139,-0.208416640356254,0.0669806377658647,0.31415177451984
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34535,0.0347820576254045,0.0745517090369586,-0.111339292087034,0.180903407337843,0.64083235181793
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34535,0.0450037382875433,0.0773665561342607,-0.106634711735608,0.196642188310694,0.560785149131237
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34535,0.0930852808276182,0.064190774642862,-0.0327286374723913,0.218899199127628,0.147052016261092
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34535,-0.0282128397624856,0.0298371931181848,-0.0866937382741279,0.0302680587491567,0.344395995463126
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34535,0.00222083375005663,0.0525586916886662,-0.100794201959729,0.105235869459842,0.966296766826012
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34463,-0.00346984258712218,0.024678993999904,-0.0518406708269341,0.0449009856526897,0.888189544828625
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29003.Recent feelings of depression,34446,0.0109017141513184,0.023548516554455,-0.0352533782954133,0.0570568065980502,0.6434124679777
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34467,0.0291827226744736,0.0193392350955714,-0.0087221781128464,0.0670876234617936,0.131332753730368
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,34474,0.0183003895433346,0.0197058237014445,-0.0203230249114966,0.0569238039981658,0.35307770865266
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,34481,-0.00318498331132559,0.0253075835167272,-0.052787847004111,0.0464178803814598,0.899852436895881
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,34436,0.0178435035870844,0.0254603113632009,-0.0320587066847894,0.0677457138589581,0.483421684593488
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,34483,-0.0122243756948699,0.0256708584665188,-0.0625392582892468,0.0380905068995069,0.633944690112235
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34468,-0.0552778882572933,0.0457681848291277,-0.144983530522384,0.034427754007797,0.227160503951427
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,34403,0.0452752636303645,0.0515861726807316,-0.0558336348238694,0.146384162084598,0.380147942933975
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,33167,0.00623431016316156,0.0384662208355408,-0.0691594826744983,0.0816281030008214,0.87125265023484
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),33167,-0.115044963453289,0.0774002694758053,-0.266749491625867,0.0366595647192897,0.13721907713847
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),33167,-0.0131337581359094,0.0362318366687081,-0.0841481580065773,0.0578806417347586,0.71699304224443
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),33167,-0.166415841961813,0.104683644868222,-0.371595785903528,0.0387641019799022,0.111938174262046
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),33167,-0.0767561712773379,0.0662666973357106,-0.206638898055331,0.0531265555006548,0.246776721641864
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),33167,-0.0390095061704552,0.069683718387453,-0.175589594209863,0.0975705818689526,0.575624762998988
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),33167,-0.00386564685700972,0.0794962523156506,-0.159678301395685,0.151947007681665,0.961217841280779
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),33167,0.0961035573801604,0.0917857368171604,-0.083796486781474,0.276003601541795,0.295109064626426
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),33167,-0.022934558391859,0.0702938318875853,-0.160710468891526,0.114841352107808,0.744230179713317
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,33167,0.0129414670579912,0.0387471419045414,-0.06300293107491,0.0888858651908924,0.738389120611082
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,33167,0.0380464798831142,0.0586615305621617,-0.0769301200187228,0.153023079784951,0.516629351288134
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,33167,0.0102189261216182,0.0911212884188635,-0.168378799179354,0.188816651422591,0.910709895890879
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,33167,0.0133606571095498,0.122387363956484,-0.22651857624516,0.253239890464259,0.913072574939262
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,33167,-0.0181107004426132,0.078261478614603,-0.171503198527235,0.135281797642009,0.816999628822824
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,33167,0.16890799196845,0.134100497814648,-0.0939289837482608,0.43174496768516,0.207860870713767
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,33167,0.0503852809600523,0.127260854458978,-0.199045993779544,0.299816555699648,0.692172790733275
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,33167,-0.121152349860237,0.0672919155172548,-0.253044504274057,0.0107398045535822,0.0718321000915618
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,33167,-0.0103093638644606,0.066034267456619,-0.139736528079434,0.119117800350513,0.875940927609508
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,33167,-0.18707128777654,0.0907345462365062,-0.364910998400092,-0.00923157715298784,0.0392618235463044
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,34317,0.0259956937789198,0.0219280731512434,-0.0169833295975172,0.0689747171553569,0.235849041034993
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,34331,0.0394131999366052,0.0225184616367205,-0.00472298487136688,0.0835493847445773,0.0801042225574237
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29060.Recent worrying too much about different things,34322,0.0476702097667256,0.0211069439267149,0.00630059967036447,0.0890398198630867,0.0239357237660174
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29061.Recent trouble relaxing,34328,0.0231298717549664,0.0222038365323223,-0.0203896478483852,0.066649391358318,0.297573469002112
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29062.Recent restlessness,34340,0.0195931245374925,0.0322245115036773,-0.043566918009715,0.0827531670847001,0.543188648878977
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,34305,0.00934247497837878,0.0233436455299462,-0.0364110702603158,0.0550960202170734,0.689006912402514
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29064.Recent feelings of foreboding,34295,0.0299951489272882,0.0252848811359954,-0.0195632180992627,0.0795535159538392,0.235537256515273
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,33167,0.0203657998693086,0.0379547725140785,-0.0540255542582851,0.0947571539969024,0.591570948312684
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,33167,-0.0354391798030991,0.0671622886059428,-0.167077265470747,0.0961989058645488,0.597745398189856
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',33167,-0.14585730447228,0.0832404221538409,-0.309008531893809,0.0172939229492479,0.0797674928839891
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,33167,-0.0568030260084998,0.0907204292972094,-0.23461506743103,0.121009015414031,0.531244313151297
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,33167,0.0130266499401638,0.0622849173622442,-0.109051788089835,0.135105087970163,0.834339046119337
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,33167,0.000803402804073827,0.0614165275735939,-0.11957299124017,0.121179796848318,0.989563297573172
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,33167,-0.00818281468772454,0.0631722374534506,-0.132000400096488,0.115634770721039,0.896939840132529
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,33167,0.0287602714952318,0.0567922234087524,-0.0825524863859228,0.140073029376386,0.612580163193502
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,33167,-0.0948642675825973,0.076549974848996,-0.24490221828663,0.055173683121435,0.215287697412695
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29076.Felt loved as a child,34298,0.026370615099347,0.0207119928622178,-0.0142248909105998,0.0669661211092939,0.202975336876089
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29077.Physically abused by family as a child,34310,-0.0445508140686618,0.0286231231039544,-0.100652135352412,0.0115505072150888,0.119630294579865
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29078.Felt hated by family member as a child,34289,0.0083409923916212,0.0269090597380698,-0.0444007646949957,0.0610827494782381,0.756590588434988
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29079.Sexually molested as a child,34180,-0.0139496541970968,0.034221867436409,-0.0810245143724584,0.0531252059782648,0.683558720560822
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,34266,-0.00636279591072943,0.0291321202728204,-0.0634617516454574,0.0507361598239986,0.82711289310424
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34290,-0.000488642505269272,0.0353658715421491,-0.0698057507278814,0.0688284657173429,0.988976434630056
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34209,0.0298015281437345,0.0268098439174617,-0.0227457659344905,0.0823488222219595,0.26634228756486
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34293,0.00352925462135649,0.0299863308530888,-0.0552439538506975,0.0623024630934105,0.906311376451983
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34249,0.0499721916467287,0.0370805439440821,-0.0227056744836721,0.12265005777713,0.177796969677749
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34256,0.00554994729756489,0.0371144662066053,-0.0671944064673814,0.0782943010625112,0.881133813308018
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,34287,-0.0431613989597631,0.03460431374466,-0.110985853899297,0.0246630559797704,0.212323168490088
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,34298,0.00110236503160588,0.0248960559614997,-0.0476939046529335,0.0498986347161452,0.96468314672915
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,34307,-0.0212919068739737,0.0220714630132227,-0.0645519743798902,0.0219681606319428,0.334728608704964
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,34314,-0.0249225231483772,0.0282265270138237,-0.0802465160954716,0.0304014697987172,0.377286512060981
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34298,-0.0130698460131717,0.0279940656371446,-0.0679382146619751,0.0417985226356317,0.6405966635881
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,34313,-0.0372752441232124,0.0184526076066613,-0.0734423550322686,-0.00110813321415626,0.0434048931943494
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33046,-0.0181355950938174,0.0225895941468195,-0.0624111996215836,0.0261400094339487,0.422095433622009
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33064,-0.0249867488027459,0.0231695512686531,-0.070399069289306,0.0204255716838142,0.280871934420699
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29104.Ever used cannabis,34306,-0.0270830882733967,0.0281765339095067,-0.0823090947360299,0.0281429181892364,0.336478707201596
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29108.Ever thought that life not worth living,34251,0.0127290372343287,0.0224004020617542,-0.0311757508067095,0.0566338252753669,0.569877981431624
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29109.Ever contemplated self-harm,34288,0.00166142445542857,0.0294502501839748,-0.056061065905162,0.0593839148160191,0.95501266230352
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29111.Ever self-harmed,34302,-0.0133966563979908,0.0455834859762036,-0.10274028891135,0.0759469761153683,0.768846045298475
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34297,-0.0175410442426981,0.0312321075531084,-0.0787559750467905,0.0436738865613943,0.574377525220369
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33883,0.068441850187053,0.0820936071159301,-0.0924616197601699,0.229345320134276,0.404468357990416
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33883,0.0416627856802753,0.0630361208291564,-0.0818880111448712,0.165213582505422,0.508670070777074
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33883,0.140563348211763,0.0637118815682925,0.01568806033791,0.265438636085617,0.0273916050008725
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33883,0.0295829589458506,0.0827877102145114,-0.132680953074592,0.191846870966293,0.720848913529627
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34290,-0.0259773536274831,0.0206241898601607,-0.066400765753398,0.0144460584984318,0.207858908178019
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X29153.Pain or discomfort today,34302,0.0033669921091941,0.0198030665175931,-0.0354470182652883,0.0421810024836765,0.864994932632798
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29154.Anxiety or depression today,34302,0.040194761029742,0.0237738693780994,-0.00640202295133284,0.0867915450108168,0.0909235111908898
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,34052,0.0238058144738874,0.019255168583971,-0.0139343159506959,0.0615459448984707,0.216364796536285
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34265,0.026733106261624,0.0212436635597201,-0.0149044743154274,0.0683706868386754,0.208275709109307
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34265,-0.0240596558207127,0.0208406649460209,-0.0649073591149136,0.0167880474734883,0.248340886701539
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34265,-0.0244786639519576,0.0304147173280714,-0.0840915099149775,0.0351341820110622,0.420937532564313
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34265,0.00143452418298966,0.0265875015536962,-0.0506769788622549,0.0535460272282342,0.956972248861235
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34265,-0.0813919648080514,0.0393883025152302,-0.158593037737903,-0.00419089187820031,0.0388169587854578
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34265,-0.0163332033357122,0.0208338314121242,-0.0571675129034756,0.0245011062320511,0.433073692260942
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34267,0.000238363331150473,0.0231777976606536,-0.0451901200837305,0.0456668467460315,0.991794810374306
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34267,0.000845285215185279,0.0324861042332149,-0.0628274790819158,0.0645180495122864,0.979241994119132
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34267,-0.0117140436396152,0.0674761013024825,-0.143967202192481,0.12053911491325,0.862181170424602
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34267,0.0496484179428867,0.044698665492663,-0.0379609664227327,0.137257802308506,0.266709201077279
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34267,-0.0495526525915601,0.0631088151068839,-0.173245930201053,0.0741406250179323,0.432358881564495
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34267,-0.00859786598621529,0.0330204670924549,-0.073317981487427,0.0561222495149964,0.794576206376057
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34158,0.0227965862430471,0.0240252640404324,-0.0242929312762004,0.0698861037622947,0.342715993592719
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,34241,0.0154814002767222,0.0215530968248791,-0.0267626695000408,0.0577254700534852,0.472594885376373
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29173.Frequency of feeling left out,34180,-0.00565416586531449,0.0223358540454121,-0.0494324397943222,0.0381241080636932,0.800163034662923
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,34214,0.00608439286096927,0.0232730479117875,-0.0395307810461342,0.0516995667680727,0.793762466442284
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,34287,0.0102080387264762,0.0194435683550834,-0.0279013552494873,0.0483174327024398,0.599589117327455
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29176.Ability to make it through stressful events,34287,-0.0105734474095104,0.0189498059345664,-0.0477150670412606,0.0265681722222399,0.576876702496648
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29177.Quick recovery from stressful events,34287,-0.00139261089884485,0.0192262221009751,-0.0390760062167561,0.0362907844190664,0.942258881601903
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,34287,-0.0169880326673209,0.0190072913834677,-0.0542423237789176,0.0202662584442758,0.3714700539894
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,34287,0.00881008438692097,0.019264041902242,-0.0289474377414733,0.0465676065153152,0.647441732368714
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,34287,-0.00200486687361873,0.0191400106773508,-0.0395192878012262,0.0355095540539888,0.916578364173942
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29181.General happiness,34227,0.0123776100648606,0.0200063087564609,-0.0268347550978028,0.051589975227524,0.536138087568264
PLA2G4A,Cytosolic phospholipase A2,Mental health,X29182.Belief that own life is meaningful,34131,-0.00277946443900345,0.0197881827976165,-0.0415643027223317,0.0360053738443248,0.88829882809688
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29663,0.0282019815568157,0.0261719159741643,-0.0230949737525463,0.0794989368661777,0.281277120087026
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2946.Father's age,30752,0.0098284825690638,0.0188788590675506,-0.0271740812033354,0.046831046341463,0.602658262600173
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,30380,0.0107431004080857,0.0146964333746272,-0.0180619090061836,0.039548109822355,0.464807727948874
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51384,0.100739428612629,0.0062405127738751,0.0885080235758342,0.112970833649425,2.39838524515741e-58
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51384,0.0163073840023794,0.00733419617390956,0.00193235950151667,0.0306824085032422,0.0261922151093286
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51384,-0.0397953172528644,0.00796410523450145,-0.0554049635124872,-0.0241856709932415,5.86437696717355e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51384,-0.0125885940265403,0.00773170357794826,-0.0277427330393189,0.00256554498623832,0.103498725608254
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51384,-0.0327434433616209,0.00614842822911291,-0.0447943626906823,-0.0206925240325596,1.01483358935725e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51383,-0.0539233331433081,0.00615420334656233,-0.0659855717025703,-0.041861094584046,2.02810283256349e-18
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51383,-0.0568398140147704,0.00602528785875065,-0.0686493782179216,-0.0450302498116191,4.27341296852147e-21
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51384,0.0275234248714914,0.00582581836318267,0.0161048208796534,0.0389420288633295,2.31973386328866e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30080.Platelet count,51384,0.35593930182842,0.00578329386375798,0.344604045855455,0.367274557801386,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30090.Platelet crit,51384,0.317296781747384,0.00602774394435393,0.30548240361645,0.329111159878317,0
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51384,-0.17005186401944,0.00589296439321166,-0.181602074230135,-0.158501653808745,2.32072485014709e-180
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51384,-0.102952810084256,0.00594241294950105,-0.114599939465278,-0.0913056807032343,7.01712969866812e-67
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51346,0.0553281233463411,0.00622424419629205,0.0431286047216087,0.0675276419710735,6.53567356631018e-19
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30130.Monocyte count,51346,0.0542989901297707,0.00631212472161366,0.0419272256754079,0.0666707545841334,8.22965061684497e-18
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51346,0.0897359321588157,0.00620194389973563,0.0775801221153339,0.101891742202298,2.86385087760302e-47
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51346,0.0533362500732507,0.00612092434793072,0.0413392383513065,0.0653332617951949,3.10552875669964e-18
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30160.Basophill count,51346,0.133281555471809,0.0126995169264019,0.108390502296061,0.158172608647557,1.02116740620475e-25
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51346,-0.0654677094129811,0.0571111243220311,-0.177405513084162,0.0464700942581999,0.251672351530152
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51346,-0.0303285910551793,0.00615388181868543,-0.0423901994198028,-0.0182669826905559,8.34123099141837e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51346,-0.0172810075852284,0.00623464554364378,-0.0295009128507702,-0.00506110231968655,0.00557906216508027
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51346,0.0267113533264355,0.00610040079698256,0.0147545677643496,0.0386681388885213,1.19882220659811e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51346,0.0204856659965929,0.00605904056043388,0.00860994649814246,0.0323613854950432,0.000723231145914878
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51346,-0.00656795571587982,0.00579567753858057,-0.0179274836914977,0.00479157225973809,0.257119084370551
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51346,-0.0657788441065683,0.0571168208056912,-0.177727812885723,0.0461701246725864,0.249473311621278
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,50897,0.0429960699360159,0.00635166773732127,0.0305468011708662,0.0554453387011656,1.32151043233159e-11
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,50897,0.0464401067293436,0.00656510465767981,0.0335725016002912,0.0593077118583961,1.5452056769108e-12
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,50897,-0.0144885587527254,0.00609287387804417,-0.026430591553692,-0.00254652595175887,0.0174161773966589
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,50897,-0.0143250136801923,0.00615401388471927,-0.0263868808942421,-0.00226314646614254,0.0199328192667545
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,50897,0.0132145918646114,0.00642297063297915,0.000625569423972265,0.0258036143052505,0.0396579653286706
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50897,0.03705188910524,0.00653035169106333,0.0242523997907559,0.0498513784197242,1.41125385870123e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,50897,0.0395471086131987,0.00670071278493541,0.0264137115547252,0.0526805056716721,3.63660696400612e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,32222,0.0333778656482344,0.01181878344946,0.0102130500872927,0.056542681209176,0.00475288085137581
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51436,-0.0149084818550167,0.0063975773953153,-0.0274477335498347,-0.00236923016019869,0.0197959223339687
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51382,-0.0103425644514343,0.00595054113492688,-0.022005625075891,0.00132049617302243,0.0822067299862963
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51354,-0.0110321726697235,0.0062685267803329,-0.023318485159176,0.00125413981972898,0.0784309223002994
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30600.Albumin,48601,0.0384925888347881,0.00654816345094282,0.0256581884709402,0.051326989198636,4.19747314772351e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,50980,0.0643029919984681,0.00621232988413175,0.0521268254255699,0.0764791585713663,4.62893013215241e-25
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,50988,0.0291538897744359,0.00648937969419439,0.0164347055738149,0.0418730739750569,7.06708587976648e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,48382,-0.0055465967920231,0.00719248012459432,-0.019643857836228,0.00855066425218177,0.440616103715186
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,50879,0.0798233468828883,0.00616743080139928,0.0677351825121457,0.0919115112536309,3.37528805230039e-38
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,50909,0.00654891599913764,0.00627441241258419,-0.00574893232952738,0.0188467643278027,0.296610751019666
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,45103,-0.0342130732831573,0.00698756021704212,-0.0479086913085599,-0.0205174552577547,9.84038689688441e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30670.Urea,50975,-0.0175004734115928,0.0064735334039321,-0.0301885988832998,-0.00481234793988593,0.00686802745306944
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30680.Calcium,48608,0.0769230135497071,0.00627217490145083,0.0646295507428635,0.0892164763565507,1.78642917252235e-34
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30690.Cholesterol,50988,0.0751377824149367,0.0063561948617562,0.0626796404858946,0.0875959243439789,3.65352592980318e-32
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30700.Creatinine,50981,-0.0427163404375728,0.00706604535634421,-0.0565657893360074,-0.0288668915391381,1.51125290172431e-09
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30710.C-reactive protein,50921,0.102756948510232,0.00678614264799191,0.0894561089201678,0.116057788100296,1.40429898838924e-51
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30720.Cystatin C,50983,0.023433269384893,0.00694838908334989,0.00981442678152723,0.0370521119882588,0.00074602232298821
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50984,0.0774982598164314,0.00635091517950067,0.06505046606461,0.0899460535682527,3.71334706414363e-34
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30740.Glucose,48580,0.0287802660018165,0.00679701185555181,0.0154581227649349,0.042102409238698,2.30161426099616e-05
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50819,0.0394183478407985,0.00692675067214343,0.0258419165233973,0.0529947791581996,1.27829321652279e-08
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,48593,-0.0334037782532636,0.00755421623241384,-0.0482100420687947,-0.0185975144377325,9.82763834633337e-06
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30770.IGF-1,50840,0.00143947844177434,0.00622953098944233,-0.0107704022975326,0.0136493591810813,0.817259629075609
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30780.LDL direct,50933,0.0769847153610517,0.00619409704341063,0.0648442851559668,0.0891251455661365,2.29109604930659e-35
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,45673,-0.00798323031725869,0.00681941318791289,-0.021349280165568,0.00538281953105058,0.241747667281395
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30810.Phosphate,48560,0.0632237475545621,0.00677421481902148,0.04994628650928,0.0765012085998442,1.11519037156441e-20
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30830.SHBG,48333,-0.0529674706305423,0.00713776541728363,-0.0669574908484182,-0.0389774504126663,1.20359813202192e-13
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30840.Total bilirubin,50891,-0.061199067501536,0.00623712392295038,-0.0734238303905187,-0.0489743046125532,1.09228109139351e-22
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30850.Testosterone,46453,-0.00360598823854299,0.0110567017501789,-0.0252771236688936,0.0180651471918076,0.744324579325327
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30860.Total protein,48598,0.13185883078187,0.00633693006194804,0.119438447860452,0.144279213703289,2.51606905866475e-95
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30870.Triglycerides,50978,0.119694699748381,0.00687068030940731,0.106228166341942,0.133161233154819,1.35877887695435e-67
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30880.Urate,50950,0.0390852125460212,0.00758253166608019,0.024223450480504,0.0539469746115384,2.55943670300081e-07
PLA2G4A,Cytosolic phospholipase A2,Blood and urine assays,X30890.Vitamin D,49441,-0.0216778974412014,0.00680656545819271,-0.0350187657392591,-0.00833702914314366,0.00145006256876152
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3137.Number of measurements made,49858,-0.0186873685509581,0.014206580371703,-0.0465322660794959,0.00915752897757973,0.188386602908921
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3143.Ankle spacing width,40250,-0.0237831587408041,0.0108432237695878,-0.0450358773291962,-0.00253044015241196,0.028295538216425
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40249,-0.00849853941551279,0.0087994511501843,-0.025745463669874,0.00874838483884844,0.334157375881522
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3146.Speed of sound through heel,40250,-0.0185372435841943,0.00847994711283492,-0.0351579399253507,-0.00191654724303781,0.0288295477297444
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40250,-0.0156738384727173,0.0085866743993506,-0.0325037202954445,0.00115604335000983,0.0679644243390139
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),40248,-0.0152654290225192,0.00856434286509875,-0.0320515410381127,0.0015206829930744,0.0746966757482582
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3526.Mother's age at death,40999,0.00332912594179345,0.00796216441217533,-0.0122767163060702,0.0189349681896571,0.67586611647096
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),40374,0.00178021096665019,0.0079072484353701,-0.0137179959666752,0.0172784178999756,0.821875904415401
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30205,-0.0238088499945332,0.0135631492546024,-0.0503926225335539,0.00277492254448744,0.0792428967775634
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4100.Ankle spacing width (left),33404,0.00440156046290477,0.0136241704488756,-0.0223018136168914,0.031104934542701,0.746649791070326
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33402,-0.0334656536446509,0.0111531488843699,-0.0553258254580159,-0.0116054818312859,0.0027022918957764
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),33404,-0.0259560777623127,0.0108657719302825,-0.0472529907456664,-0.00465916477895909,0.0169244199537371
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33404,-0.0296030750898264,0.0109584611774284,-0.051081658997586,-0.00812449118206686,0.00691803920508932
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),33402,-0.028783418744829,0.0109268040185443,-0.0501999546211758,-0.00736688286848223,0.00844802350143179
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33404,-0.029615066649145,0.010957840843887,-0.0510924347031635,-0.00813769859512657,0.00689215764437163
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4119.Ankle spacing width (right),33405,0.0216849084675322,0.0134315793930115,-0.00464098714277038,0.0480108040778347,0.106460330746852
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33405,-0.0267484347311412,0.0111580182480353,-0.0486181504972903,-0.00487871896499208,0.0165395186471215
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),33405,-0.0271957043288052,0.0108911165477676,-0.0485422927624296,-0.0058491158951807,0.0125408156478545
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33405,-0.028347605843214,0.0109743395112775,-0.0498573112853178,-0.00683790040111018,0.00980795076325798
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),33402,-0.0288335840117981,0.0109491531959412,-0.0502939242758429,-0.00737324374775324,0.0084678157894485
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33405,-0.0283486005659876,0.0109743748426264,-0.0498583752575353,-0.00683882587443986,0.00980561238170949
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4194.Pulse rate,33672,0.0590320647047206,0.0106028717299192,0.038250436114079,0.0798136932953622,2.65582785075552e-08
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4195.Pulse wave reflection index,33672,-0.0325466632290213,0.0106364611044369,-0.0533941269937177,-0.0116991994643249,0.00222036164696395
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,33669,-0.0071655259708018,0.00970973405970695,-0.0261966047278274,0.0118655527862238,0.460549369294578
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,33672,-0.000777396218682368,0.00939602366822191,-0.0191936026083973,0.0176388101710326,0.934062679335308
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4199.Position of pulse wave notch,33672,0.0398479886548628,0.0104513958305864,0.0193632528269134,0.0603327244828122,0.000138355084543113
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33672,0.0114107536436843,0.00939036335257947,-0.00699435852737149,0.0298158658147401,0.22433782522659
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),33572,-0.0783916575744101,0.0644623008688012,-0.20473776727726,0.0479544521284403,0.223983946128284
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4270.Volume level set by participant (left),33481,-0.0166705743711942,0.0204063821441235,-0.0566670833736764,0.0233259346312879,0.413990312718921
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),33570,-0.0757499816010575,0.0617295813095699,-0.196739960967814,0.0452399977656994,0.219806919816066
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X4277.Volume level set by participant (right),33461,-0.00487187698451417,0.0202909399619208,-0.044642119309879,0.0348983653408507,0.810257346863869
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4288.Time to answer,33743,0.0272618005813063,0.0118305815372499,0.00407386076829638,0.0504497403943162,0.0212249529035016
PLA2G4A,Cytosolic phospholipase A2,Cognitive function,X4290.Duration screen displayed,33743,0.0150859850452839,0.0105467489183027,-0.00558564283458939,0.0357576129251571,0.152638177845538
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X46.Hand grip strength (left),52207,-0.0231407511002661,0.00903803923745615,-0.0408553080056802,-0.00542619419485203,0.0104612327137098
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X47.Hand grip strength (right),52212,-0.0108843646138516,0.00900286331745993,-0.0285299767160731,0.00676124748836986,0.226677287612286
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X48.Waist circumference,52297,0.0919775765891679,0.0120237895527158,0.0684109490658449,0.115544204112491,2.08054238386746e-14
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X4803.Tinnitus,33580,0.025371509355213,0.0248657377825754,-0.0233653366986349,0.0741083554090609,0.307594242278723
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4825.Noisy workplace,33718,0.0198330422524166,0.035402308924409,-0.049555483239425,0.0892215677442582,0.575343689428966
PLA2G4A,Cytosolic phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,33662,-0.0147089013868986,0.0404947247423987,-0.0940785618820001,0.064660759108203,0.716441370604829
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X49.Hip circumference,52294,-0.0256883181963464,0.0102107045198544,-0.045701299055261,-0.00567533733743176,0.0118810829973261
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X50.Standing height,52292,-0.0241886513913306,0.00835957743806326,-0.0405734231699345,-0.00780387961272658,0.0038123869670992
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X5057.Number of older siblings,32637,-0.0084826615635305,0.0218064979874263,-0.051223397618886,0.034258074491825,0.697288510746976
PLA2G4A,Cytosolic phospholipase A2,Physical measures,X51.Seated height,52164,-0.0235645412302135,0.00839228658059923,-0.040013422928188,-0.00711565953223902,0.00499035194912989
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5181.Ever had eye surgery,30708,0.0314279797267604,0.0498585197100812,-0.0662947189049988,0.12915067835852,0.528493083780577
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30690,0.0164790214534748,0.0121602232037472,-0.00735501602586975,0.0403130589328194,0.175416351582534
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30693,0.015638583632891,0.0120173526536434,-0.00791542756825004,0.0391925948340321,0.193192360982191
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),30616,0.0103357751524582,0.0121164630094382,-0.0134124923460407,0.034084042650957,0.393672668165169
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),30618,0.0182672442702052,0.0121880455002332,-0.00562132491025178,0.0421558134506622,0.133980939998064
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",30671,0.0180825927212773,0.0260176995632509,-0.0329120984226944,0.0690772838652491,0.487074249503118
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),30671,-0.252717541030296,0.194963990297823,-0.63484696201403,0.129411879953438,0.194945488202357
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5201.logMAR, final (right)",30619,0.00573345449136197,0.0126263890181022,-0.0190142679841184,0.0304811769668424,0.649783592910715
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5202.Number of rounds to result (right),30671,0.00611788128083287,0.0244010347594895,-0.0417081468477665,0.0539439094094322,0.802037187817394
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",30670,0.0304335589734634,0.0261417581627258,-0.0208042870254792,0.081671404972406,0.244398118573338
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),30670,-0.197853149365387,0.16299318301737,-0.517319788079432,0.121613489348659,0.224842048967858
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5208.logMAR, final (left)",30607,0.00379109725148649,0.0125003709397676,-0.020709629790458,0.028291824293431,0.761687666075093
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5209.Number of rounds to result (left),30668,0.0462468377467578,0.0244873547759378,-0.00174837761408035,0.094242053107596,0.0589919400149516
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30368,0.0233873219293727,0.0124253876334764,-0.000966437832241103,0.0477410816909865,0.0598550958869555
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30368,0.0402785134529094,0.0125253521596722,0.0157288232199519,0.0648282036858669,0.00130799778138946
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),30368,0.0178371781140599,0.0124515975185998,-0.00656795302239575,0.0422423092505155,0.152047534876617
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),30368,0.033793094514353,0.0124704687323778,0.00935097579889252,0.0582352132298134,0.00675077453243828
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30366,0.0258407178924473,0.0123984288945047,0.00153979725921809,0.0501416385256765,0.0371854352178404
PLA2G4A,Cytosolic phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30366,0.0226209492684177,0.0123419626136474,-0.00156929745433122,0.0468111959911665,0.0668753291046693
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),30366,-0.00283784471485626,0.0126777760914124,-0.0276862858540246,0.0220105964243121,0.822886386373272
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),30366,0.00924249803931495,0.0125262303563846,-0.0153089134591989,0.0337939095378288,0.460633960347517
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29949,0.0676521161512555,0.112335461118878,-0.152525387641746,0.287829619944257,0.547043929479414
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52203,0.00924214488410754,0.035185213607001,-0.0597208737856145,0.0782051635538296,0.792805909389983
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52203,-0.102368672172975,0.0361135592420085,-0.173151248287312,-0.0315860960586383,0.00459115507040476
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52203,-0.0813588072822437,0.0918587794236002,-0.2614020149525,0.0986844003880126,0.375789896758962
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52203,-0.056394076743475,0.0153187420380737,-0.0864188111380995,-0.0263693423488504,0.000232416441797839
PLA2G4A,Cytosolic phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52203,0.0518680458680984,0.0139988669838853,0.0244302665796832,0.0793058251565137,0.000211667117546428
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37304,0.0027155801248206,0.0174013462045504,-0.0313910584360981,0.0368222186857393,0.875991528712181
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37304,0.0123496076845587,0.0433725282783876,-0.072660547741081,0.0973597631101983,0.775852983272757
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37304,-0.0169871345011082,0.0339933190125621,-0.0836140397657299,0.0496397707635134,0.617280945226936
PLA2G4A,Cytosolic phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37304,9.0549254321971e-05,0.020912399674464,-0.0408977541076275,0.0410788526162715,0.996545292649058
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52288,-0.0219495408039466,0.0288588736425763,-0.0785129331433961,0.034613851535503,0.446913196525005
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52288,-0.0219495408039466,0.0288588736425763,-0.0785129331433961,0.034613851535503,0.446913196525005
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52288,-0.0158254555257931,0.0230362926590365,-0.0609765891375046,0.0293256780859185,0.492101514496214
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52288,-0.0489972747654881,0.0359846810085118,-0.119527249542171,0.021532700011195,0.173330497511336
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52288,-0.0240332225859932,0.0894033746257655,-0.199263836852494,0.151197391680507,0.788071851835793
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52288,0.0852840201353634,0.0609490090662609,-0.0341760376345079,0.204744077905235,0.161743665924332
PLA2G4A,Cytosolic phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52288,0.227049830484753,0.0987667041783818,0.0334670902951244,0.420632570674381,0.021520833803505
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52203,-0.00951596891806451,0.0185207776507897,-0.0458166931136123,0.0267847552774833,0.607396169413587
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52203,0.0112681854429794,0.0308381157214157,-0.0491745213709953,0.0717108922569542,0.714817127645615
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52203,0.0044198055249469,0.0164008233247218,-0.0277258081915079,0.0365654192414017,0.787557096221908
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52203,0.0732825156181246,0.0304793181774919,0.0135430519902405,0.133021979246009,0.0162083938449947
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52203,-0.00393464655918569,0.0296477326884277,-0.062044202628504,0.0541749095101326,0.894421136490098
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52203,0.0213540319542536,0.0166366106914331,-0.0112537250009552,0.0539617889094625,0.199307850546731
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31882,-0.157235709205779,0.0614353593038435,-0.277649013441312,-0.0368224049702454,0.0105058817982619
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31882,-0.0447722395609519,0.0403503015492989,-0.123858830597578,0.0343143514756739,0.267212203783957
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31882,0.0130342286893213,0.0514852845315401,-0.0878769289924973,0.11394538637114,0.800148366550947
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31882,0.090335532082878,0.0457337221750696,0.00069743661974167,0.179973627546014,0.0482767440865631
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52198,0.0069683529263929,0.0451289173202667,-0.0814843250213297,0.0954210308741155,0.877287648289191
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52198,0.0295273521260902,0.0772707722904417,-0.121923361563175,0.180978065815356,0.702369096681162
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52198,0.0126225609262564,0.123300152851841,-0.229045738663351,0.254290860515864,0.918461647411803
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52198,-0.146039467481284,0.123235442770471,-0.387580935311408,0.095502000348839,0.236010054600908
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52198,-0.0657279052451916,0.0377552069000583,-0.139728110769306,0.00827230027892269,0.0817128177110143
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52198,0.114514265671403,0.0537612461665191,0.00914222318502561,0.219886308157781,0.0331760692517052
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52198,0.0249837304048436,0.0267447209517286,-0.0274359226605443,0.0774033834702316,0.350231772913568
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33986,0.0485180685954694,0.040595386430304,-0.0310488888079265,0.128085025998865,0.232053418584748
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33986,0.00492710710284374,0.0470370732897652,-0.087265556545096,0.0971197707507835,0.916576833467476
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33986,-0.0211970676424221,0.0611364140736608,-0.141024439226797,0.0986303039419531,0.728811176856229
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33986,0.0468879412507023,0.0211838317428309,0.00536763103475371,0.0884082514666508,0.0268948122509687
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37588,0.00489057181344757,0.0212883263532236,-0.0368345478388706,0.0466156914657657,0.818304990632821
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37588,-0.00294270612842819,0.0185541308911939,-0.0393088026751683,0.0334233904183119,0.873985576400078
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37588,0.00687034035130658,0.0174095214362377,-0.0272523216637193,0.0409930023663324,0.693121490450357
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37588,0.0632189355975986,0.0418297569427855,-0.018767388010261,0.145205259205458,0.13072620219164
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37588,0.0257089171036417,0.02507717909431,-0.0234423539212059,0.0748601881284894,0.305291598584364
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37588,-0.0595429330565324,0.0290119781589773,-0.116406410248128,-0.00267945586493702,0.0401547634774253
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52203,-0.00984977123956756,0.0407051260059448,-0.0896318182112194,0.0699322757320843,0.808798498351342
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52203,0.0119107767515352,0.0259373461562684,-0.038926421714751,0.0627479752178213,0.646084530194178
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52203,-0.113385140695907,0.101129108620009,-0.311598193591124,0.08482791219931,0.262215874945613
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52203,-0.0153640465501169,0.0256582470438307,-0.0656542107560251,0.0349261176557913,0.549314055396508
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52203,0.0217174224282637,0.030816717381773,-0.0386833436400114,0.0821181884965389,0.480985056942065
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52203,-0.0354987800961255,0.0345969624619542,-0.103308826521556,0.0323112663293048,0.304869238753329
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52203,-0.0135927914488289,0.0122347692035581,-0.0375729390878028,0.0103873561901449,0.266579281389791
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28847,-0.0897126988055978,0.0413748786932007,-0.170807461044271,-0.00861793656692436,0.0301901664127534
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28847,0.0754472646795424,0.0547141419474129,-0.0317924535373868,0.182686982896472,0.167984842099025
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28847,-0.00224136028536137,0.0362712821378222,-0.073333073275493,0.0688503527047702,0.950729412546671
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28847,0.0139202081981548,0.0327100104773874,-0.0501914123375245,0.0780318287338341,0.670446291329712
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52330,0.0276321510571611,0.0139507275339074,0.000288725090702595,0.0549755770236195,0.0476351815104894
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52330,0.0202148023763883,0.0373372540876636,-0.0529662156354324,0.093395820388209,0.588228610915162
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52330,0.0265852598708597,0.0136269316436813,-0.000123526150755771,0.0532940458924751,0.0510747650692129
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52330,-0.0181359191214635,0.0135813449581109,-0.044755355239361,0.00848351699643389,0.181771034738407
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52330,0.038223642612595,0.0195841388331156,-0.000161269500311659,0.0766085547255016,0.0509760744622667
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52330,-0.0266311715560515,0.0173502839357773,-0.060637728070175,0.00737538495807201,0.124816616106271
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52330,-0.0100033512970376,0.0145722615320322,-0.0385649838998206,0.0185582813057455,0.492425473547265
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52330,0.121781862113176,0.0396308100736359,0.0441054743688495,0.199458249857502,0.00212187783425779
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43633,-0.0237505761963462,0.0145239106671943,-0.0522174411040469,0.00471628871135455,0.102007991070284
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43633,0.000429213505052815,0.0160759298766441,-0.0310796090531696,0.0319380360632753,0.978699976690769
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43633,0.0302043214260987,0.0161554175502523,-0.00146029697239572,0.0618689398245932,0.0615532945128722
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43633,-0.0293468775252744,0.0206085679056732,-0.069739670620394,0.0110459155698451,0.154458850856355
PLA2G4A,Cytosolic phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43633,-0.00291618302258195,0.0146243495703375,-0.0315799081804434,0.0257475421352795,0.841947282603092
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52080,-0.00165366055480321,0.0147416538496318,-0.0305473021000815,0.0272399809904751,0.910684630585641
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52080,0.00968627613172552,0.0118487873933207,-0.013537347159183,0.032909899422634,0.413654984583161
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52080,-0.0134018745175085,0.0129625268604653,-0.0388084271640205,0.0120046781290036,0.301194922472934
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52080,-0.046479942541977,0.0284367262562908,-0.102215926004307,0.00925604092035308,0.102164462068607
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52092,-0.00611454488188284,0.0133854423160502,-0.0323500118213412,0.0201209220575755,0.647814376888258
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52092,-0.0485966894860638,0.0240170256480893,-0.0956700597563189,-0.00152331921580869,0.0430387842375013
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52203,-0.000745835539512161,0.0127874426423241,-0.0258092231184674,0.0243175520394431,0.953489679192354
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52203,0.00207901214063444,0.0144999070905011,-0.0263408057567478,0.0304988300380167,0.885990276364924
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52203,-0.0201471526103143,0.018972862728271,-0.0573339635577255,0.0170396583370969,0.288293444568246
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52203,0.0392220120266274,0.0274101434508264,-0.0145018691369922,0.0929458931902471,0.152461376616797
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52203,0.0132212510586929,0.0283447700221858,-0.0423344981847913,0.0687770003021771,0.640901304831089
PLA2G4A,Cytosolic phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52203,0.0158705292770724,0.0367730144610631,-0.0562045790666114,0.0879456376207561,0.66604942317133
PLA2G4A,Cytosolic phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40250,-0.0156772464963472,0.00858665705292881,-0.0325070943200876,0.00115260132739331,0.0679040333373808
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51686,-0.0194203409743234,0.0114672343697982,-0.041896120339128,0.00305543839048113,0.0903621613318907
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X874.Duration of walks,47581,-0.00638297410514174,0.00657714525931789,-0.0192741788134048,0.00650823060312132,0.331818485068611
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50607,-0.0101991639751642,0.0111157049788007,-0.0319859457336136,0.0115876177832853,0.358865376361875
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X894.Duration of moderate activity,44398,-0.00701763791407876,0.0136115438692469,-0.0336962638978027,0.0196609880696452,0.606163857105107
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30499,0.0116105486057908,0.013554227463862,-0.0149557372233787,0.0381768344349603,0.391700036941652
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50596,-0.0109486746995979,0.0114836359039412,-0.0334566010713227,0.0115592516721269,0.340388485732384
PLA2G4A,Cytosolic phospholipase A2,Physical activities,X914.Duration of vigorous activity,38227,-0.00337452987054581,0.00878568178521098,-0.0205944661695593,0.0138454064284677,0.700914520421874
